<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="pmc-domain-id">440</journal-id><journal-id journal-id-type="pmc-domain">plosone</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>PLOS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10723714</article-id><article-id pub-id-type="pmcid-ver">PMC10723714.1</article-id><article-id pub-id-type="pmcaid">10723714</article-id><article-id pub-id-type="pmcaiid">10723714</article-id><article-id pub-id-type="pmid">38100469</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0294804</article-id><article-id pub-id-type="publisher-id">PONE-D-22-25311</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject><subj-group><subject>Patients</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Analgesics</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Analgesics</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject><subj-group><subject>Patients</subject><subj-group><subject>Inpatients</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Critical Care and Emergency Medicine</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject><subj-group><subject>Alcohol Consumption</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject><subj-group><subject>Alcohol Consumption</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Data Management</subject><subj-group><subject>Data Visualization</subject><subj-group><subject>Infographics</subject><subj-group><subject>Charts</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug Therapy</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Addiction</subject><subj-group><subject>Alcoholism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Addiction</subject><subj-group><subject>Alcoholism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Mental Health and Psychiatry</subject><subj-group><subject>Substance-Related Disorders</subject><subj-group><subject>Alcoholism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Substance-Related Disorders</subject><subj-group><subject>Alcoholism</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Harm reduction strategies in acute care for people who use alcohol and/or drugs: A scoping review</article-title><alt-title alt-title-type="running-head">Harm reduction strategies in acute care: A scoping review</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3402-8189</contrib-id><name name-style="western"><surname>Crowther</surname><given-names initials="D">Daniel</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9977-0467</contrib-id><name name-style="western"><surname>Curran</surname><given-names initials="J">Janet</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4699-7278</contrib-id><name name-style="western"><surname>Somerville</surname><given-names initials="M">Mari</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sinclair</surname><given-names initials="D">Doug</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wozney</surname><given-names initials="L">Lori</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MacPhee</surname><given-names initials="S">Shannon</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rose</surname><given-names initials="AE">Annette Elliott</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9849-383X</contrib-id><name name-style="western"><surname>Boulos</surname><given-names initials="L">Leah</given-names></name><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Caudrella</surname><given-names initials="A">Alexander</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>School of Nursing, Dalhousie University, Halifax, Nova Scotia, Canada</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Quality and Patient Safety, IWK Health, Halifax, Nova Scotia, Canada</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Mental Health and Addictions Program, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>The Maritime Strategy for Patient Oriented Research SUPPORT Unit, Halifax, NS, Canada</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Mental Health and Addictions Service, St Michael&#8217;s Hospital, Toronto, Ontario, Canada</addr-line></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Bluthenthal</surname><given-names initials="RN">Ricky N.</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Keck School of Medicine, University of Southern California, UNITED STATES</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>jacurran@dal.ca</email></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>18</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">450167</issue-id><elocation-id>e0294804</elocation-id><history><date date-type="received"><day>12</day><month>9</month><year>2022</year></date><date date-type="accepted"><day>9</day><month>11</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>12</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>15</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-29 02:25:20.013"><day>29</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 Crowther et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Crowther et al</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pone.0294804.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="pone.0294804.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="editor-report" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0294804"><pub-id pub-id-type="doi">10.1371/journal.pone.0294804</pub-id></related-article><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="reviewed-article" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0294804"><pub-id pub-id-type="doi">10.1371/journal.pone.0294804</pub-id></related-article><abstract><sec id="sec001"><title>Background</title><p>People who use alcohol and/or drugs (PWUAD) are at higher risk of infectious disease, experiencing stigma, and recurrent hospitalization. Further, they have a higher likelihood of death once hospitalized when compared to people who do not use drugs and/or alcohol. The use of harm reduction strategies within acute care settings has shown promise in alleviating some of the harms experienced by PWUAD. This review aimed to identify and synthesize evidence related to the implementation of harm reduction strategies in acute care settings.</p></sec><sec id="sec002"><title>Methods</title><p>A scoping review investigating harm reduction strategies implemented in acute care settings for PWUAD was conducted. A search strategy developed by a JBI-trained specialist was used to search five databases (Medline, Embase, CINAHL, PsychInfo and Scopus). Screening of titles, abstracts and full texts, and data extraction was done in duplicate by two independent reviewers. Discrepancies were resolved by consensus or with a third reviewer. Results were reported narratively and in tables. Both patients and healthcare decision makers contributing to the development of the protocol, article screening, synthesis and feedback of results, and the identification of gaps in the literature.</p></sec><sec id="sec003"><title>Findings</title><p>The database search identified 14,580 titles, with 59 studies included in this review. A variety of intervention modalities including pharmacological, decision support, safer consumption, early overdose detection and turning a blind eye were identified. Reported outcome measures related to safer use, managed use, and conditions of use. Reported barriers and enablers to implementation related to system and organizational factors, patient-provider communication, and patient and provider perspectives.</p></sec><sec id="sec004"><title>Conclusion</title><p>This review outlines the types of alcohol and/or drug harm reduction strategies, which have been evaluated and/or implemented in acute care settings, the type of outcome measures used in these evaluations and summarizes key barriers and enablers to implementation. This review has the potential to serve as a resource for future harm reduction evaluation and implementation efforts in the context of acute care settings.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>Strategy for Patient-Oriented Research Evidence</institution></funding-source><award-id>Q80-21</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9977-0467</contrib-id><name name-style="western"><surname>Curran</surname><given-names>Janet</given-names></name></principal-award-recipient></award-group><funding-statement>This project is funded by the Strategy for Patient-Oriented Research Evidence Alliance in partnership with the Canadian Institutes of Health Research (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://sporevidencealliance.ca/" ext-link-type="uri">https://sporevidencealliance.ca/</ext-link> Grant number: Q80-21). The grant was awarded to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="5"/><page-count count="30"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>This review relies on data from publicly available published literature. Included articles can be identified through the reference list.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>This review relies on data from publicly available published literature. Included articles can be identified through the reference list.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Substance use is a global health concern, with drug and/or alcohol misuse contributing to over 5% of the global burden of disease [<xref rid="pone.0294804.ref001" ref-type="bibr">1</xref>]. People who use alcohol and/or drugs (PWUAD) are at an increased risk of infectious disease, recurring hospitalizations and death [<xref rid="pone.0294804.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0294804.ref003" ref-type="bibr">3</xref>]. A recent cross-Canadian study highlighted the increasing potency, unpredictability, and poor quality of unregulated substances placing PWUAD at a greater risk of serious health outcomes, such as poisoning [<xref rid="pone.0294804.ref004" ref-type="bibr">4</xref>]. While better management of substance use is recognized as a priority by national and international governing bodies, there are challenges in supporting PWUAD in the health care system. The complex social and health care needs of PWUAD create significant barriers in accessing care [<xref rid="pone.0294804.ref005" ref-type="bibr">5</xref>]. A 2010 report from the World Health Organization found that mental health care services, which provide substance use supports, are underutilized by PWUAD [<xref rid="pone.0294804.ref001" ref-type="bibr">1</xref>]. In addition to poor access to substance use support across the health and social care system, PWUAD often face stigma when seeking treatment for substance use disorders from health care providers [<xref rid="pone.0294804.ref006" ref-type="bibr">6</xref>]. Improved health system supports are urgently needed to ensure all PWUAD receive adequate care.</p><p>Harm reduction is an approach that emphasizes working with people where they are at, rather than focusing solely on drug and alcohol abstinence [<xref rid="pone.0294804.ref007" ref-type="bibr">7</xref>]. Harm reduction strategies are a promising approach for health care providers and health systems to improve the care of PWUAD. Harm reduction strategies such as safe injection sites, needle exchange programs and methadone maintenance treatment have led to reduced deaths from overdose [<xref rid="pone.0294804.ref008" ref-type="bibr">8</xref>], a decrease in human immunodeficiency virus (HIV) infections [<xref rid="pone.0294804.ref009" ref-type="bibr">9</xref>], and fewer hospitalizations [<xref rid="pone.0294804.ref003" ref-type="bibr">3</xref>]. Additionally, the recent decision by the U.S. Department of Health and Human Services&#8217; to remove the X-waiver requirement for the use of medication-assisted treatment for people who use opioids highlight that harm reduction strategies are increasingly being viewed as valid and necessary approaches to care [<xref rid="pone.0294804.ref010" ref-type="bibr">10</xref>]. Despite advances in our understanding of the effectiveness of harm reduction strategies, greater public buy in, and the need for enhanced access to health care services for PWUAD, there are gaps in how and when PWUAD receive care.</p><p>While the majority of harm reduction work for PWUAD has been conducted in the community, evidence suggests that hospitals represent an ideal setting for implementing harm reduction strategies [<xref rid="pone.0294804.ref011" ref-type="bibr">11</xref>]. Hospitals are an ideal point of care for PWUAD, with rates of hospital admission and emergency department (ED) utilization higher for PWUAD than the general population [<xref rid="pone.0294804.ref012" ref-type="bibr">12</xref>]. In a qualitative study, PWUAD reported that hospital-based harm reduction strategies would enhance patient-centred care by promoting a culturally safe environment, ensuring timely access to care and prioritizing substance use symptoms [<xref rid="pone.0294804.ref002" ref-type="bibr">2</xref>]. However, health care providers repeatedly report lack of training as being a barrier to providing quality care to PWUAD in the hospital setting [<xref rid="pone.0294804.ref013" ref-type="bibr">13</xref>]. Further, there is little known about how harm reduction strategies are implemented in the inpatient and ED setting, making it challenging to design effective and acceptable interventions for this population. Therefore, the aim of this study is to map the evidence related to the implementation of harm reduction strategies in inpatient and ED settings for PWUAD. This study will answer four research questions:</p><list list-type="order"><list-item><p>What harm reduction strategies have been evaluated to help alleviate negative health outcomes associated with substance use within inpatient settings and EDs?</p></list-item><list-item><p>What are the commonly reported outcome measures used to evaluate harm reduction strategies and their implementation in these settings?</p></list-item><list-item><p>How are harm reduction strategies implemented in inpatient settings and EDs?</p></list-item><list-item><p>What are the reported barriers and enablers to their implementation?</p></list-item></list></sec><sec sec-type="materials|methods" id="sec006"><title>Methods</title><sec id="sec007"><title>Study design</title><p>This review followed the JBI methodology for scoping reviews [<xref rid="pone.0294804.ref014" ref-type="bibr">14</xref>] and was registered with Open Science Framework (Registration DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.17605/OSF.IO/P7BHN" ext-link-type="uri">10.17605/OSF.IO/P7BHN</ext-link>). This review utilized an integrated knowledge translation (iKT) approach [<xref rid="pone.0294804.ref015" ref-type="bibr">15</xref>]. The methods of the review were previously reported [<xref rid="pone.0294804.ref016" ref-type="bibr">16</xref>] and are briefly summarized below.</p></sec><sec id="sec008"><title>Search strategy</title><p>The search strategy was designed by a JBI-trained information specialist (LB), in collaboration with the study team and the principle knowledge user (AC), and was peer reviewed by a second research librarian (<xref rid="pone.0294804.s001" ref-type="supplementary-material">S1 Table</xref>). Five electronic databases were searched for articles: Medline, Embase, CINAHL, PsychInfo and Scopus. An additional search of the grey literature was completed following the systematic approach of Godin et al. [<xref rid="pone.0294804.ref017" ref-type="bibr">17</xref>].</p></sec><sec id="sec009"><title>Inclusion criteria</title><p>The participants, concept and context framework [<xref rid="pone.0294804.ref014" ref-type="bibr">14</xref>] was used to characterize the research question. Participants included either PWUAD who were accessing acute care settings for any health condition, or participants who provided care to PWUAD in acute care settings. Participants of any race, age and gender were considered for inclusion. Any studies evaluating interventions or implementation of interventions with the goal of reducing harms related to alcohol and/or substance use were considered. Studies utilizing patient reported outcome measures, patient reported experience measures and health outcome measures we considered for inclusion. Studies which took place in acute care settings (e.g., inpatient settings, emergency departments) were also considered. Outpatient services, primary care, community settings, long term inpatient settings (e.g., nursing homes, prisons) were excluded. Opinion papers, commentaries, newspaper articles were not included. Evidence syntheses were not included, however, the reference lists of any relevant evidence synthesis were searched for applicable articles. Grey literature sources (e.g., policy documents, unpublished program evaluations) were searched and assessed for eligibility. Articles were only included if they reported in English and the full text was available.</p></sec><sec id="sec010"><title>Screening approach</title><p>Articles retrieved from the search were managed using Covidence [<xref rid="pone.0294804.ref018" ref-type="bibr">18</xref>]. Following de-duplication, articles were independently screened by two reviewers, starting with titles and abstracts, and followed by full text papers. Any disagreements between reviewers were resolved through discussion or by consultation with the research team.</p></sec><sec id="sec011"><title>Data extraction</title><p>Data were extracted from each included study using a predetermined data extraction form. The data extraction form was pilot tested with six team members using one of the included studies. The team met to review any discrepancies in data extraction and to refine the data extraction tool. The data from each study were independently extracted in duplicate. The team met regularly to discuss any concerns related to the data extraction process until data extraction was complete.</p><p>Extracted data included characteristic and demographic details such as country, year of publication, study design, objective, participant sample, and setting characteristics. Intervention details included the type and length of intervention, the population targeted by the intervention, what type of drug use the intervention addressed and the reported outcomes measures. Implementation details included whether provider training, sustainability, quality and performance, cost, communication or participant compensation was mentioned. Additionally, data related to reported barriers or enablers to implementation was extracted.</p></sec><sec id="sec012"><title>Data synthesis and presentation</title><p>Extracted data were synthesized into four major sections (population characteristics, intervention characteristics, characteristics of outcome measures and implementation characteristics) using tables, figures and narrative description. The reporting and presentation of this review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses for Scoping Reviews (PRISMA-ScR) (<xref rid="pone.0294804.s002" ref-type="supplementary-material">S2 Table</xref>) [<xref rid="pone.0294804.ref019" ref-type="bibr">19</xref>].</p><p>To further elucidate the harm reduction principles present in each intervention approach, the interventions were coded by Hawk et al.&#8217;s [<xref rid="pone.0294804.ref020" ref-type="bibr">20</xref>] six harm reduction principles for healthcare settings. These include: humanism, pragmatism, individualism, autonomy, incrementalism and accountability without termination. Interventions which contained pharmacological approaches were coded under pragmatism. Interventions which provided multiple services, tailored their services to meet patient needs and allowed shared decision making in terms of goal setting were coded to individualism. Interventions which supported patients during readmission, provided follow-up and ongoing care and aimed to &#8220;meet patients where they are&#8221; were coded to incrementalism. Interventions which provided information and/or referrals to additional services and care and allowed patients to make decisions related to their care were coded under autonomy. Interventions which provided education to patients and caregivers related to risks associated with continued drug use and overdose were coded to accountability without termination. Finally, interventions which enacted system changes and emphasized empathy, support, understanding and compassion were coded under humanism.</p><p>Barriers and enablers to implementation were organized based on the following pre-defined categories: system and organizational factors, provider-patient communication, patient perceptions and provider perceptions. System and organizational factors encompass barriers/enablers related to law and policy, funding and resources, and structural and environmental factors such availability of hospital space and the physical location of a hospital. Provider-patient communication encompass barriers/enablers related to communication between providers and patients. Finally, patient perceptions and provider perceptions encompass barrers/enablers related to how patient and providers perceive the harm reduction strategy.</p></sec><sec id="sec013"><title>Patient, decision maker and community organization engagement</title><p>Patients and healthcare decision makers were engaged throughout this review to: a) ensure that our research questions aligned with priorities relevant to all partners; b) allow partners with lived experiences of harm reduction programs to contextualize our findings and; c) inform the identification of key gaps in the literature that may have been overlooked without their engagement.</p><p>In addition to patients and healthcare decision makers, the preliminary findings of this review were also shared with members of a community organization which provides harm reduction services as part of their community health promotion and disease prevention mandate. Individuals from this organization were given the opportunity to provide feedback and comment on the findings, drawing on their own experiences of receiving, providing and advocating for care. This feedback was used to interpret review findings and integrated into the discussion. Reporting of engagement adhered to the Guidance for Reporting Involvement of Patients and the Public revised short form (GRIPP2-SF) checklist (<xref rid="pone.0294804.s003" ref-type="supplementary-material">S3 Table</xref>) [<xref rid="pone.0294804.ref021" ref-type="bibr">21</xref>].</p></sec><sec id="sec014"><title>Critical appraisal</title><p>All studies were critically appraised by two independent reviewers using the Mixed Methods Appraisal Tool (MMAT) [<xref rid="pone.0294804.ref022" ref-type="bibr">22</xref>]. The MMAT can be applied to a range of study designs and is therefore useful for scoping reviews. Based on the quality of the report, each article received a score ranging from 0 to 5. Differences in scoring were resolved by consensus or a third reviewer. Scores are listed in <xref rid="pone.0294804.t001" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="pone.0294804.t001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0294804.t001</object-id><label>Table 1</label><caption><title>Summary of included articles.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0294804.t001g" position="float" orientation="portrait" xlink:href="pone.0294804.t001.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Author, Year</th><th align="left" rowspan="1" colspan="1">Country</th><th align="left" rowspan="1" colspan="1">Setting</th><th align="left" rowspan="1" colspan="1">Study design</th><th align="left" rowspan="1" colspan="1">Study Objectives</th><th align="left" rowspan="1" colspan="1">MMAT</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Banta-Green et al., 2019</bold> [<xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Randomized Controlled Trial (RCT)</td><td align="left" rowspan="1" colspan="1">Tested an intervention for opioid users at elevated risk for overdose to determine the impact on participants&#8217; subsequent opioid overdoses, ED visits and hospitalisations.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Boora et al., 2021</bold> [<xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;MHA</td><td align="left" rowspan="1" colspan="1">Pre-/Post-test Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Assess the feasibility of a new seamless care transition and to assess its affect on our outcome measure of wait time to first outpatient MHT assessment and readmission rate to hospital.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Boudreaux et al., 2015</bold> [<xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Quasi Experimental: Non-equivalent groups</td><td align="left" rowspan="1" colspan="1">Describes initial development, functionality, acceptability, and, overall feasibility of a new telehealth SBIRT delivery model.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Brooks et al., 2019</bold> [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Identify the proportion of intakes in which patients were offered and accepted syringes and analyse demographic characteristics that predict offering and accepting syringes.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Byrne et al., 2020</bold> [<xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Compare the effectiveness of an inpatient link to recovery coaching services to the current standard of care.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Christian et al., 2021</bold> [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Evaluate a hospitalist-led interprofessional program created to identify hospitalized patients with OUD, initiate buprenorphine in the inpatient setting, and provide bridge prescription and access to outpatient treatment programs</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Cushman et al., 2016</bold> [<xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Determine if inpatient buprenorphine initiation and linkage to outpatient buprenorphine reduce injection opiate users&#8217; frequency of injection opiate use.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn002" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>D&#8217;Onofrio et al., 2008</bold> [<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Assess the efficacy of an emergency practitioner performed intervention in reducing alcohol consumption and negative consequences</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>D&#8217;Onofrio et al., 2012</bold> [<xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Evaluate the efficacy of the Brief Negotiation Interview</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>D&#233;sy and Perhats, 2008</bold> [<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Mixed Methods Design (Chart Review and Semi-structured Interviews)</td><td align="left" rowspan="1" colspan="1">Conduct the SBIRT process with eligible patients. Explore barriers and enablers to implementing and maintaining SBIRT</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn003" ref-type="table-fn">**</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Devries et al., 2019</bold> [<xref rid="pone.0294804.ref025" ref-type="bibr">25</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Assess whether routine screening increases identification of candidates for take-home naloxone, increases naloxone prescribing to those who need it, and identify which screening tool questions were highest yield for identifying naloxone candidates.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dong et al., 2020</bold> [<xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">Report the implementation of a supervised consumption services in acute care setting for inpatients.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dwyer et al., 2015</bold> [<xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design</td><td align="left" rowspan="1" colspan="1">Evaluate the feasibility of an ED-based overdose prevention and intervention program, and describe overdose risk knowledge, opioid use, overdose, and overdose response actions among ED patients</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Eswaran et al., 2020</bold> [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Qualitative</td><td align="left" rowspan="1" colspan="1">Summarize the individual and collective experiences in implementing take-home naloxone programs within the Chicago area.</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Eswaran et al., 2020</bold> [<xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED &amp; Inpatient</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Describe the development of an ED-based take-home naloxone program</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Gerdtz et al., 2020</bold> [<xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>]</td><td align="left" rowspan="1" colspan="1">Australia</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Prospective Observational Design</td><td align="left" rowspan="1" colspan="1">To determine the prevalence of amphetamine-type stimulant among patients admitted to the ED. Explore the referral outcomes for those who tested positive for, or who self&#8208;reported amphetamine&#8208;type stimulant use.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Gryczynski et al., 2021</bold> [<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED &amp; Inpatient</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Examine the effectiveness of Navigation Services to Avoid Rehospitalization (NavSTAR) in promoting engagement in care and reducing acute care use</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Holland et al., 2020</bold> [<xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Mixed Methods Design (Chart Review and Semi-structured Interviews)</td><td align="left" rowspan="1" colspan="1">To assess feasibility and implementation of a centered computerized clinical decision support system</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn003" ref-type="table-fn">**</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hurt et al., 2020</bold> [<xref rid="pone.0294804.ref049" ref-type="bibr">49</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design</td><td align="left" rowspan="1" colspan="1">Study ED patients with active opioid misuse regarding their prior knowledge of naloxone and to identify barriers to obtaining and using naloxone kits</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Jakubowski et al., 2019</bold> [<xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">To evaluate the processes of a naloxone program and the patients reached</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Johnson et al., 2016</bold> [<xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">Describes the implementation of a naloxone distribution program</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Johnson et al., 2020</bold> [<xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Mixed Methods (Retrospective Chart Review + Directed Content Analysis)</td><td align="left" rowspan="1" colspan="1">Describes an implementation-focused process evaluation of a brief intervention for substance users</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Joosten et al., 2009</bold> [<xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>]</td><td align="left" rowspan="1" colspan="1">Netherlands</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;MHA</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Examine the effect of shared-decision making on patients and clinicians perceptions of the therapeutic alliance</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn003" ref-type="table-fn">**</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kestler et al., 2017</bold> [<xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design</td><td align="left" rowspan="1" colspan="1">Determine patient acceptance of ED-based naloxone program and examined factors related to acceptance.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kestler et al., 2019</bold> [<xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Mixed Methods (Cross Sectional Survey using Closed-and Open-ended questions)</td><td align="left" rowspan="1" colspan="1">Determine why intravenous drug users accept or decline take home naloxone</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kirby et al., 2021</bold> [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;Rehab</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Evaluate the effect of this new program content (the opioid series) on rates of MAT within 30 days of completion of inpatient rehabilitation with a diagnosis of OUD. Evaluate the effect of MAT and completion of the opioid series was investigated in relation to rates of OUD-related ED visits and/or hospitalization admission within 1 year after rehabilitation program completion</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kosteniuk et al., 2021</bold> [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">ED &amp; Inpatient</td><td align="left" rowspan="1" colspan="1">Qualitative</td><td align="left" rowspan="1" colspan="1">Examine key factors that shape patients&#8217; decisions to attend or not attend a novel supervised consumption service embedded within a large, urban acute care hospital.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ladak et al., 2021</bold> [<xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;MHA</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">We present the case of a 40-year-old patient with OUD using illicit fentanyl, heroin, and oxycodone preoperatively and admitted for an elective liver resection for steroid-induced hepatoma.&#160;</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Liebling et al., 2021</bold> [<xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED &amp; Inpatient</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Describe the implementation of hospital-based peer recovery support services for substance use disorder</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Monti et al., 1999</bold> [<xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Evaluate the use of brief motivational interview to reduce alcohol related consequences and use among adolescents treated in the ER following an alcohol related event</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Moore et al., 2021</bold> [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Evaluate the feasibility of the Point of Care naloxone protocol, and report the rate of obtainment in comparison to previously published references in the literature</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Mullennix et al., 2020</bold> [<xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design</td><td align="left" rowspan="1" colspan="1">Describe the implementation of a clinical nurse specialist&#8211;led emergency department overdose education and naloxone distribution program.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nordqvist et al., 2005</bold> [<xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>]</td><td align="left" rowspan="1" colspan="1">Sweden</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Prospective Cohort Design</td><td align="left" rowspan="1" colspan="1">Evaluate whether screening without one-to-one feedback and screening with simply written advice are sufficient to initiate a self-regulation process concerning risky drinking among emergency care patients</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>O&#8217;Brien et al., 2019</bold> [<xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Describe a take home naloxone program offered to patients presenting in ED with opioid overdose</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Papp et al., 2019</bold> [<xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Determine the impact naloxone rescue kits had on repeat opioid overdose related ED visits, hospitalization, and death</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Parappilly et al., 2020</bold> [<xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Qualitative</td><td align="left" rowspan="1" colspan="1">Describe the experience of patients with severe alcohol use disorder on a managed alcohol program while admitted to an acute care hospital</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Prach et al., 2019</bold> [<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Implement and evaluate an inpatient naloxone program in a community teaching hospital</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn003" ref-type="table-fn">**</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ray et al., 2020</bold> [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Evaluate the feasibility of implementing a comprehensive, multidisciplinary treatment approach in the management of patients with opioid use disorder admitted to cardiovascular surgery for medical or surgical treatment</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2019</bold> [<xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Determine whether ED naloxone distribution and recovery coach consultation improves frequency and timeliness of linkage to opioid treatment, reduces recurrent opioid overdose, and reduces incidence of opioid overdose death</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2018</bold> [<xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Mixed Methods (Retrospective Chart Review And Open-ended survey questions)</td><td align="left" rowspan="1" colspan="1">Measure the sustainability of an ED take-home naloxone and peer recovery coach consultation program for ED patients at risk of opioid overdose.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2019</bold> [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Qualitative</td><td align="left" rowspan="1" colspan="1">Assess the facilitators and barriers of implementing treatment standards for care of adult patients with opioid use disorder</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn002" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2021</bold> [<xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Evaluated the influence of Levels of Care policy implementation on offering and receipt of take home naloxone, ED behavioral counselling, and referral to treatment following and ED visit for opioid overdose</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Schipper et al., 2018</bold> [<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>]</td><td align="left" rowspan="1" colspan="1">Netherlands</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;Critical Care</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">Explore the effects of substituting street cannabis with a low THC medicinal cannabis variant in patients with a psychotic disorder and comorbid CUD in terms of acceptance, craving and severity of psychotic symptoms</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Schreyer et al., 2020</bold> [<xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">Present the case of a patient found after a presumed opioid overdose in our ED</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sise et al., 2005</bold> [<xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Interrupted Time Series Design</td><td align="left" rowspan="1" colspan="1">Describe the implementation of a screening, brief intervention and referral program at a urban teaching hospital trauma center</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Snyder et al., 2021</bold> [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Evaluated the implementation of low-threshold ED buprenorphine treatment at 52 hospitals participating in the CA Bridge Program</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn006" ref-type="table-fn">*****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Stein et al., 2021</bold> [<xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Test whether a brief intervention in skin cleaning would result in greater reductions in follow up ED visits or hospitalization rates when compared with a usual care condition</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tait et al., 2004</bold> [<xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>]</td><td align="left" rowspan="1" colspan="1">Australia</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Evaluate the effectiveness of a brief intervention enhanced by a consistent support person in facilitating attendance for substance use treatment following a hospital alcohol or other drug presentation.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn003" ref-type="table-fn">**</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Thompson et al., 2020</bold> [<xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Determine impact of a substance use consultant on length of stay and hazard ratio for a routine hospital discharge</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Townsend, 2021</bold> [<xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Investigated the utilization of Peer Recovery Specialists in an ED setting</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Train et al., 2020</bold> [<xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">A quality improvement (QI) project was aimed to increase the prescription of naloxone kits at patient discharge</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Van Heukelom et al., 2019</bold> [<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Cross Sectional Design</td><td align="left" rowspan="1" colspan="1">A quality improvement study was undertaken to explore the perception of nurses in caring for patients on hospital based managed alcohol program</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wakeman et al., 2017</bold> [<xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Prospective Cohort Design</td><td align="left" rowspan="1" colspan="1">Determine whether inpatient addiction consultation improves substance use outcomes 1 month after discharge.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weiland et al., 2008</bold> [<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td><td align="left" rowspan="1" colspan="1">Australia</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Qualitative</td><td align="left" rowspan="1" colspan="1">Evaluate emergency staff attitudes in performing alcohol screening and delivering opportunistic brief intervention; and to document process issues associated with the introduction of routine clinician-initiated opportunistic screening and training and administration of brief intervention.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weinrib et al., 2017</bold> [<xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">ED &amp; Inpatient</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">This report describes the postsurgical management of a patient with complex chronic pain and high-dose opioid dependence after urgent surgery.</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weinstein et al., 2020</bold> [<xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">Inpatient&#8212;General Medicine</td><td align="left" rowspan="1" colspan="1">Retrospective Cohort Design (Chart Review)</td><td align="left" rowspan="1" colspan="1">Evaluate whether an addiction consult is associated with acute care utilization</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Welch et al., 2019</bold> [<xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>]</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">ED</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">Describe the Relay program (a harm reduction strategy)</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn005" ref-type="table-fn">****</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Young et al., 2002</bold> [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8211;Critical Care</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">A case illustrating the potential harms of discontinuation of outpatient methadone upon admission to an intensive care unit</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Young et al., 2018</bold> [<xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>]</td><td align="left" rowspan="1" colspan="1">Canada</td><td align="left" rowspan="1" colspan="1">Inpatient&#8211;Rehab</td><td align="left" rowspan="1" colspan="1">Case Report</td><td align="left" rowspan="1" colspan="1">A case report of a dedicated team using harm reduction principles that was formed and trained to work with PWUAD in a spinal cord program</td><td align="left" rowspan="1" colspan="1">
<xref rid="t001fn004" ref-type="table-fn">***</xref>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>MMAT:</p></fn><fn id="t001fn002"><p>* (1) = one out of five criterion met</p></fn><fn id="t001fn003"><p>** (2) = two out of five criterion met</p></fn><fn id="t001fn004"><p>*** (3) = three out of five criterion met</p></fn><fn id="t001fn005"><p>**** (4) = four out of five criterion met</p></fn><fn id="t001fn006"><p>***** (5) = five out of five criterion met.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="results" id="sec015"><title>Results</title><sec id="sec016"><title>Included studies</title><p>The database search returned 36,264 records, with 14,580 titles remaining after deduplication. No additional relevant articles were found through the grey literature search. A total of 549 full texts were assessed for eligibility, with 59 studies meeting the inclusion criteria for this review. Our patient partner screened 982 titles and abstracts. An overview of the screening process can be found in <bold><xref rid="pone.0294804.g001" ref-type="fig">Fig 1</xref></bold> (Preferred Reporting Items for Systematic and Meta Analyses (PRISMA) Flow Diagram).</p><fig position="float" id="pone.0294804.g001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0294804.g001</object-id><label>Fig 1</label><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0294804.g001.jpg"/></fig></sec><sec id="sec017"><title>General characteristics of included studies</title><p>Included studies utilized a range of study designs with retrospective chart reviews (n = 14) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>&#8211;<xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>] being the most common, followed by randomized controlled trials (n = 10) [<xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>&#8211;<xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>], cross-sectional designs (n = 10) [<xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>&#8211;<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>], case reports (n = 9) [<xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>&#8211;<xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>], qualitative studies (n = 5) [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>&#8211;<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>], mixed methods studies (n = 5) [<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>&#8211;<xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>], prospective cohort design (n = 2) [<xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>], prospective observational design (n = 1) [<xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>], pre-/post-test design (n = 1) [<xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>], interrupted time series design (n = 1) [<xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>], and quasi experimental: non-equivalent group design (n = 1) [<xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]. The majority of included articles were conducted in the United States (n = 39) [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>&#8211;<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>&#8211;<xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>&#8211;<xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>&#8211;<xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], followed by Canada (n = 14) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>&#8211;<xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>], Australia (n = 3) [<xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>], Netherlands (n = 2) [<xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>], and Sweden (n = 1) [<xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>]. The majority of articles were published between 2019&#8211;2021 (n = 39) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>&#8211;<xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>&#8211;<xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>&#8211;<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>&#8211;<xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>&#8211;<xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>], while the remaining were published between 1999 and 2018 (n = 20) [<xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>&#8211;<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>&#8211;<xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>] (<xref rid="pone.0294804.t001" ref-type="table">Table 1</xref>).</p><p>The reported sample size across studies ranged from 1 to 30,263. The majority of studies targeted patient populations alone (n = 46) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>&#8211;<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>&#8211;<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>&#8211;<xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>&#8211;<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>&#8211;<xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>&#8211;<xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], followed by both patients and health care providers (HCPs) (n = 8) [<xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>&#8211;<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>], patients and caregivers (n = 3) [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>] and HCPs alone (n = 2) [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>].</p></sec><sec id="sec018"><title>Intervention characteristics</title><p>Thirty-two of the included articles reported delivering interventions in EDs [<xref rid="pone.0294804.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>&#8211;<xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0294804.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>&#8211;<xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>&#8211;<xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], while twenty-two studies [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>&#8211;<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>] took place in inpatient settings and five studies [<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>] included both ED and inpatient settings. Of the articles that delivered interventions in inpatient settings, specific departments included general medicine (n = 15) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>&#8211;<xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>], critical care (n = 2) [<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>], psychiatric, mental health or pain programs (n = 3) [<xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>], and rehabilitation programs (n = 2) [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>].</p><p>Interventions targeted several types of drug use, including opioid use (n = 31) [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>&#8211;<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>&#8211;<xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>&#8211;<xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>], alcohol use (n = 8) [<xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>], amphetamine use (n = 1) [<xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>] or cannabis use (n = 1) [<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>]. Interventions which were not targeted to address a specific drug or targeted poly-drug use were categorized under substance use and represented 18 of the included articles [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>&#8211;<xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]. Interventions targeting alcohol and opioid use were predominantly set in the ED, whereas interventions targeting substance use were predominantly set in inpatient settings.</p><p>Interventions which targeted patients and caregivers did not report adapting intervention components based on the presence of the caregiver, only that caregivers were welcome to participate in the intervention alongside patients. Interventions which targeted HCP populations primarily utilized education or clinical pathway decision support materials. Only two articles [<xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>] utilized policy change as a strategy, and those interventions were targeted at both patient and HCP populations.</p><p>This review identified interventions which used several different modalities to reduce harms associated with drug and/or alcohol use, these included pharmacological (n = 4) [<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>], decision support (n = 22) [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>&#8211;<xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>&#8211;<xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>&#8211;<xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], safer consumption (n = 3) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>], early overdose detection (n = 1) [<xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>] and turning a blind eye (n = 1) [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]. Twenty-eight articles [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>&#8211;<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>&#8211;<xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>&#8211;<xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>] combined pharmacological and decision support approaches, with most of these being related to naloxone education and distribution, and primarily occurring in the ED. Other pharmacological strategies included the use of buprenorphine, methadone, cannabinoid derivatives and alcohol.</p><p>Decision support covered a range of intervention approaches including education, training, counselling, referral, and clinical decision supports. The use of brief interventions was a common approach (n = 10) [<xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>] within the decision support category. These interventions exclusively occurred in the emergency departments and addressed either alcohol use (n = 6) [<xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>] or substance use (n = 4) [<xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]. The use of peer recovery supports (n = 9) [<xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>] and specialized teams (n = 4) [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>] were also common and targeted opioid and substance use exclusively.</p><p>Safer consumption approaches included supervised consumption sites (n = 2) [<xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>] and needle distribution programs (n = 1) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>]. Only one article [<xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>] reported using early overdose protection and the intervention was in the form of an emergency department bathroom sensor that detected when individuals remained immobile for a period of time. Only one article [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>] reported utilizing the turning a blind eye approach, which involved ignoring patient drug use at a park across the street from the facility. <xref rid="pone.0294804.t001" ref-type="table">Table 1</xref> presents a full overview of intervention characteristics.</p><p>All of the included interventions utilized at least two of Hawk et al.&#8217;s harm reduction principles, with pragmatism being the most common (n = 34) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>&#8211;<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>&#8211;<xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>&#8211;<xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>&#8211;<xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>&#8211;<xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>&#8211;<xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>], followed by individualism (n = 33) [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>&#8211;<xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>&#8211;<xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>&#8211;<xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>&#8211;<xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>&#8211;<xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>&#8211;<xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], incrementalism (n = 24) [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>&#8211;<xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>&#8211;<xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>], autonomy (n = 19) [<xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], accountability without termination (n = 19) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>&#8211;<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>&#8211;<xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>] and humanism (n = 14) [<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>] (<xref rid="pone.0294804.t002" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="pone.0294804.t002" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0294804.t002</object-id><label>Table 2</label><caption><title>Characteristics of interventions by setting.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0294804.t002g" position="float" orientation="portrait" xlink:href="pone.0294804.t002.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Author, Year</th><th align="center" rowspan="1" colspan="1">Population Targeted</th><th align="center" rowspan="1" colspan="1">Type of Drug Use</th><th align="center" rowspan="1" colspan="1">Intervention Approaches</th><th align="center" rowspan="1" colspan="1">Intervention Content</th><th align="center" rowspan="1" colspan="1">Humanism</th><th align="center" rowspan="1" colspan="1">Pragmatism</th><th align="center" rowspan="1" colspan="1">Individualism</th><th align="center" rowspan="1" colspan="1">Autonomy</th><th align="center" rowspan="1" colspan="1">Incrementalism</th><th align="center" rowspan="1" colspan="1">Accountability</th></tr></thead><tbody><tr><td align="left" colspan="5" style="background-color:#E7E6E6" rowspan="1">
<bold>Ambulatory: Emergency Department&#160;</bold>
</td><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Banta-Green et al., 2019</bold> [<xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Boudreaux et al., 2015</bold> [<xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Screen to identify appropriate intervention, brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change. Referral to treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>D&#8217;Onofrio et al., 2008</bold> [<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change, negotiated drinking goals, provided pamphlet of harm risks</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>D&#8217;Onofrio et al., 2012</bold> [<xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change, negotiated drinking goals</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>D&#233;sy and Perhats, 2008</bold> [<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Screen to identify appropriate intervention, brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change. Referral to treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Devries et al., 2019</bold> [<xref rid="pone.0294804.ref025" ref-type="bibr">25</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">A protocol for HCPs to teach and distribute Naloxone kits to patients</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dwyer et al., 2015</bold> [<xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Eswaran et al., 2020</bold> [<xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Gerdtz et al., 2020</bold> [<xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Amphetamine Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Screened for illicit substances, provided with a harm reduction brochure, and offered a referral.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Holland et al., 2020</bold> [<xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>]</td><td align="left" rowspan="1" colspan="1">HCP</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Clinical decision support guidance for drug therapy using a computerized system</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hurt et al., 2020</bold> [<xref rid="pone.0294804.ref049" ref-type="bibr">49</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Johnson et al., 2020</bold> [<xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; Caregivers</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Screen to identify appropriate intervention, brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change. Referral to treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kestler et al., 2017</bold> [<xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kestler et al., 2019</bold> [<xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Monti et al., 1999</bold> [<xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change, negotiated drinking goals</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Moore et al., 2021</bold> [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td><td align="left" rowspan="1" colspan="1">HCP</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Protocol for opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Mullennix et al., 2020</bold> [<xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nordqvist et al., 2005</bold> [<xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>O&#8217;Brien et al., 2019</bold> [<xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Papp et al., 2019</bold> [<xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Prach et al., 2019</bold> [<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2018</bold> [<xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program, Recovery Coach consultation and referral support</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2019</bold> [<xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program, Recovery Coach consultation and referral support</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2021</bold> [<xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Policy level changes. For Patients: education on safe opioid storage and disposal, substance use disorder screening, referral to treatment on discharge, peer recovery consultation, urine drug testing for fentanyl and fentanyl analogs, naloxone distribution. For HCP: mandated reporting of suspected opioid overdoses, staff training. Ensuring that facilities can meet these needs</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Schreyer et al., 2020</bold> [<xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Early Overdose Detection</td><td align="left" rowspan="1" colspan="1">Reverse motion detector in ED Waiting Room Washroom</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sise et al., 2005</bold> [<xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Screen to identify appropriate intervention, brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change. Referral to treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Snyder et al., 2021</bold> [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Low-threshold buprenorphine treatment approach, active patient navigation from ED care to outpatient addiction treatment, and harm reduction interventions in line with an overdose education and naloxone distribution methodology.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tait et al., 2004</bold> [<xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change. Referral to treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Thompson et al., 2020</bold> [<xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Medication treatment initiation, motivational interviewing, Naloxone training, discharge planning, and linkages to resources</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Townsend, 2021</bold> [<xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">A peer recovery specialist consulted with patients, provided support for referral and linkage to treatment</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weiland et al., 2008</bold> [<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Brief intervention to increase insight and awareness regarding substance use and motivation toward behavioral change.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Welch et al., 2019</bold> [<xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Peer navigation and support, opioid overdose education and naloxone distribution program, referral, and linkage to treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" colspan="5" style="background-color:#E7E6E6" rowspan="1">
<bold>Inpatient: General Medicine</bold>
</td><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Brooks et al., 2019</bold> [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Safer Consumption</td><td align="left" rowspan="1" colspan="1">Safe Syringe Distribution</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Byrne et al., 2020</bold> [<xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Recovery coach</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Christian et al., 2021</bold> [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Buprenorphine was initiated in-hospital by nurse; Psychospiritual care and counseling is offered by chaplain and social worker; A follow-up appointment is made for outpatient care in the community with a partner OBOT team following discharge</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Cushman et al., 2016</bold> [<xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Received buprenorphine/naloxone while in hospital and then at discharge, linked to a primary care buprenorphine clinic.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dong et al., 2020</bold> [<xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Safer Consumption</td><td align="left" rowspan="1" colspan="1">Supervised consumption service</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Jakubowski et al., 2019</bold> [<xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Johnson et al., 2016</bold> [<xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; Caregivers</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Parappilly et al., 2020</bold> [<xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Pharmacological</td><td align="left" rowspan="1" colspan="1">Alcohol is prescribed by the Addiction Medicine Consult using a customizable order set</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ray et al., 2020</bold> [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; Caregivers</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">The inpatient algorithm included assessment and evaluation, pre/post op pain management, psychotherapy, and maintenance. The discharge algorithm includes the notification of psychiatry/addiction medicine, choice between IV antibiotics, psychotherapy, treatment referral, inpatient/residential/intensive outpatient program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Samuels et al., 2019</bold> [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Policy level changes. For Patients: education on safe opioid storage and disposal, substance use disorder screening, referral to treatment on discharge, peer recovery consultation, urine drug testing for fentanyl and fentanyl analogs, naloxone distribution. For HCP: mandated reporting of suspected opioid overdoses, staff training, and ensuring that facilities are capable of meeting these needs</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Stein et al., 2021</bold> [<xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">A skin hygiene education and skills&#8208;training behavioral intervention</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Train et al., 2020</bold> [<xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Van Heukelom et al., 2019</bold> [<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Alcohol Use</td><td align="left" rowspan="1" colspan="1">Pharmacological</td><td align="left" rowspan="1" colspan="1">Small, measured doses of beverage alcohol (e.g., beer, wine, or spirits) with the intention of preventing withdrawal, reducing consumption of non-beverage alcohol (e.g., hand sanitizer or mouthwash) and ensuring that alcohol consumption occurs in a safe environment.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wakeman et al., 2017</bold> [<xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">A multidisciplinary specialty team offering pharmacotherapy initiation, motivational counseling, treatment planning, and direct linkage to ongoing addiction treatment.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weinstein et al., 2020</bold> [<xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">A multi-disciplinary team counsels about treatment options, coaches and collaborates with inpatient providers, initiate evidence-based medications for addiction and bridges patients to long-term outpatient treatment.</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" style="background-color:#E7E6E6" rowspan="1">
<bold>Inpatient: Psychiatric, Mental Health or Pain Team</bold>
</td><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Boora et al., 2021</bold> [<xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">A referral pathway and a referral form to be used by inpatient teams when a patient requires follow-up care post-discharge;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Joosten et al., 2009</bold> [<xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>]</td><td align="left" rowspan="1" colspan="1">Patients &amp; HCP</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Shared Decision Making. Both patient and clinician completed the Goals of Treatment questionnaire and discussed the results to reach a treatment agreement</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ladak et al., 2021</bold> [<xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Peer Recovery support; coaching, mentoring, and or education by individuals with lived experience of recovery</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" style="background-color:#E7E6E6" rowspan="1">
<bold>Inpatient: Rehabilitation</bold>
</td><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kirby et al., 2021</bold> [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Consists of four 1-hour group education sessions for participants. Psychologists and social workers lead 3 sessions, respectively focusing on motivational interviewing, triggers and coping skills, and coping with pain. A clinical pharmacy specialist leads a fourth session, providing education regarding MAT for OUD and the role of naloxone rescue kits for overdose.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Young et al., 2002</bold> [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support; Turning a blind-eye</td><td align="left" rowspan="1" colspan="1">The counselor, along with abstinence-based approaches, utilizes motivational interviewing rational recovery techniques and development of readiness for change&#8211;taking an individualized approach to all clients in the spinal cord program. A blind-eye is turned to drug use in an adjacent park.</td><td align="left" rowspan="1" colspan="1">&#160;</td><td align="left" rowspan="1" colspan="1">&#160;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#160;</td><td align="left" rowspan="1" colspan="1">&#10003;</td></tr><tr><td align="left" colspan="5" style="background-color:#E7E6E6" rowspan="1">
<bold>Inpatient: Critical Care</bold>
</td><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Schipper et al., 2018</bold> [<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Cannabis Use</td><td align="left" rowspan="1" colspan="1">Pharmacological</td><td align="left" rowspan="1" colspan="1">Replacing the use of street cannabis with high tetrahydrocannabinol and low cannabidiol levels by medical cannabis variants with low tetrahydrocannabinol and high cannabidiol</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Young et al., 2018</bold> [<xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological</td><td align="left" rowspan="1" colspan="1">Methadone administration to prevent the harm related to methadone treatment interruption</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" style="background-color:#E7E6E6" rowspan="1">
<bold>Combination: Emergency Department &amp; Inpatient</bold>
</td><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/><td align="left" style="background-color:#E7E6E6" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Eswaran et al., 2020</bold> [<xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Opioid overdose education and naloxone kit distribution program</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Gryczynski et al., 2021</bold> [<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">NavSTAR (harm reduction strategy), used proactive case management, advocacy, service linkage, and motivational support to resolve internal and external barriers to care and address SUD, medical, and basic needs for 3 months after discharge</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Kosteniuk et al., 2021</bold> [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Substance Use</td><td align="left" rowspan="1" colspan="1">Safer Consumption</td><td align="left" rowspan="1" colspan="1">Supervised consumption service</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Liebling et al., 2021</bold> [<xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Decision Support</td><td align="left" rowspan="1" colspan="1">Peer Recovery support; coaching, mentoring, and or education by individuals with lived experience of recovery.</td><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weinrib et al., 2017</bold> [<xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>]</td><td align="left" rowspan="1" colspan="1">Patients</td><td align="left" rowspan="1" colspan="1">Opioid Use</td><td align="left" rowspan="1" colspan="1">Pharmacological; Decision Support</td><td align="left" rowspan="1" colspan="1">Postsurgical opioid weaning is supported, and pain management is optimized using multimodal approaches, including behavioral strategies</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#10003;</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec019"><title>Characteristics of outcome measures</title><p>Reported outcome measures were organized into four categories, based on those defined by G. Alan Marlatt (1996) and the National Harm Reduction Coalition: [<xref rid="pone.0294804.ref082" ref-type="bibr">82</xref>, <xref rid="pone.0294804.ref083" ref-type="bibr">83</xref>] abstinence, safer use, managed use, and conditions of use and use itself (<xref rid="pone.0294804.t003" ref-type="table">Table 3</xref>). Safer use was comprised of outcome measures related to pharmacological distribution and/or acceptance, syringe acceptance, treatment implementation and presence of safe consumption site. Safer use outcome measures were used most frequently in ED settings. Managed use was comprised of outcome measures related to referral to and/or acceptance of care, satisfaction and/or experience of care and HCP follow-up. Conditions of use and use itself included measures related to mortality, readmission rates, leaving against medical advice (AMA), adverse events, length of stay and frequency of use of drugs and/or alcohol. One article, Schreyer et al., 2020 [<xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>], did not report outcome measures related to these categories, however they did report outcome measures related to implementation. No studies reported on abstinence.</p><table-wrap position="float" id="pone.0294804.t003" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0294804.t003</object-id><label>Table 3</label><caption><title>Characteristics of outcome measures by setting.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0294804.t003g" position="float" orientation="portrait" xlink:href="pone.0294804.t003.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Ambulatory: Emergency Department (n =) &#160;</th><th align="left" rowspan="1" colspan="1">Inpatient: General Medicine (n =)</th><th align="left" rowspan="1" colspan="1">Inpatient: Psychiatric, Mental Health or Pain Team (n =)</th><th align="left" rowspan="1" colspan="1">Inpatient: Rehab (n =)</th><th align="left" rowspan="1" colspan="1">Inpatient: Critical Care(n =)</th><th align="left" rowspan="1" colspan="1">Combination: Emergency Department &amp; Inpatient (n =)</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">Safer Use</td><td align="left" rowspan="1" colspan="1">Pharmacological Distribution/ Acceptance</td><td align="left" rowspan="1" colspan="1">11 [<xref rid="pone.0294804.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">3 [<xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Syringe Acceptance</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Treatment Implementation</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Safe Consumption Site</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref058" ref-type="bibr">58</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="3" colspan="1">Managed Use</td><td align="left" rowspan="1" colspan="1">Referral/ Acceptance of Care</td><td align="left" rowspan="1" colspan="1">7 [<xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>]</td><td align="left" rowspan="1" colspan="1">3 [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3 [<xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Satisfaction/ Experience of Care</td><td align="left" rowspan="1" colspan="1">6 [<xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>]</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>]</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">HCP Follow-up</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>]</td></tr><tr><td align="left" rowspan="6" colspan="1">Conditions of Use and Use Itself</td><td align="left" rowspan="1" colspan="1">Mortality</td><td align="left" rowspan="1" colspan="1">5 [<xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Readmission Rate</td><td align="left" rowspan="1" colspan="1">4 [<xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>]</td><td align="left" rowspan="1" colspan="1">6 [<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Leaving AMA</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>]</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref059" ref-type="bibr">59</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>]</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Adverse Events</td><td align="left" rowspan="1" colspan="1">3 [<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref060" ref-type="bibr">60</xref>]</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of Stay</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>]</td><td align="left" rowspan="1" colspan="1">4 [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1 [<xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Drug or Alcohol Use</td><td align="left" rowspan="1" colspan="1">6 [<xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>]</td><td align="left" rowspan="1" colspan="1">2 [<xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>]</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec020"><title>Characteristics of intervention implementation</title><p>Twenty-one articles reported at least one study aim related to measuring intervention implementation, with two of these described as quality improvement studies. The most commonly reported factor related to implementation was provider training (n = 33) [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>&#8211;<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>&#8211;<xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>&#8211;<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>&#8211;<xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>&#8211;<xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>&#8211;<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], followed by sustainability (n = 21) [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>&#8211;<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], providing a honorarium/credit for participants (n = 15) [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>&#8211;<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>&#8211;<xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>&#8211;<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>], quality and performance (n = 15) [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>&#8211;<xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>&#8211;<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], cost (n = 14) [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>], and communication and marketing (n = 6) [<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>]. Less than half of the articles reported implementation factors related to cost, sustainability, communication and marketing, quality and performance, and honorarium/credit for participants.</p></sec><sec id="sec021"><title>Reported barriers and enablers to implementation</title><p>Thirty-eight (64%) of the included articles reported at least one barrier and/or enabler to implementation (<xref rid="pone.0294804.t004" ref-type="table">Table 4</xref>). The most commonly reported barriers and enablers were related to system and organizational factors. Factors related to patient-provider communication, patient perspectives and provider perspectives were also reported.</p><table-wrap position="float" id="pone.0294804.t004" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0294804.t004</object-id><label>Table 4</label><caption><title>Barriers and enablers to implementation.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0294804.t004g" position="float" orientation="portrait" xlink:href="pone.0294804.t004.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>System and Organizational Factors: Reported Barriers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Time and labor a burden for HCPs [<xref rid="pone.0294804.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Inadequate training and support for HCPs [<xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Information barrier due to absence of formal guidelines [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Staffing issues [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Part-time health educators not available outside working hours [<xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Lack of resources [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Costs associated with implementation [<xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; The fast paced nature of the ED, an emphasis on throughput and the constraints of acute care in the ED [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Referrals were limited by access to specialists, and treatment services in the hospital and the surrounding community [<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Inadequate administrative support [<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Difficulty scheduling or locating patients for training.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Lack of case management when addressing complex psychosocial illnesses [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Insurance status [<xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Lack of organizational prioritization [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Unengaged and remote hospital leadership [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Poor interdepartmental communication, collaboration, and coordination [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Poor community-hospital partnerships [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Absence of local champion [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Rural and community hospitals had structural barriers to follow-up treatments [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; COVID 19 initiated closures and decreased intakes to addiction treatment programs creating barriers to care for treatment seeking patients [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Screening impacted by patient trauma [<xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Timely identification of patients [<xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; No systematic approach to selecting clients for program and inability to select clients based on potential future alcohol/drug use [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Phones not available in in all treatment areas [<xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Adaptability of intervention [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Trained patients forgetting naloxone kits at discharge; only patient who received training used their kits [<xref rid="pone.0294804.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Covering the cost of and sourcing naloxone kits [<xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Challenges related to documenting the prescribing, dispensing, and training of naloxone distribution [<xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>].</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Inability to dispense naloxone to admitted patients because admitted patients are not permitted to receive discharge medication in the ED prior to transport into the hospital [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Ambiguity on dispensing status [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Ambiguity on labeling procedures [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Ambiguity on legal liability [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Obtaining X-waiver to prescribe BUP, and access and availability to MOUD in the community [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Limited outpatient availability of specialists for OUD [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; SCS was not designed or equipped to support supervised drug inhalation [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; SCS was only available to registered inpatients, leaving visitors to use drugs in hospital in unsafe areas [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Lack of education and unclear guideline related to MAP [<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>]</td></tr><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>System and Organizational Factors: Reported Enablers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Brief interventions which require no additional resources to implement [<xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Securing funding [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Multidisciplinary team involvement including pharmacists, nurses, and practitioners from various specialties [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Community organization assistance [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Pharmacy engagement [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Knowledge of state legislation [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Collaboration with other surrounding hospitals [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Support from hospital leadership; enabling program leaders to address administrative barriers in a timely manner [<xref rid="pone.0294804.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Full time social workers with low caseloads and a modest discretionary fund [<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Communication and sharing with local champions and among colleagues [<xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Access to sterile injection supplies and ability to safely disposal of used supplies [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Partnerships between pharmacists and physicians [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Policy adaptability to local context [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Immediate intervention delivery [<xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Staff training [<xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Adopt protocols to work within the ED setting [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Use of trained providers with an awareness of harm reduction principles [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Empowering clinicians to be &#8220;changemakers&#8221; reduced the stigma in the hospital and spurred adaptation of health care system to meet patients&#8217; needs [<xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Outsourcing SBIR allowed the trauma service to continue to provide high-quality, consistent services [<xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Public pressure to address opioid overdose crisis [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Hospital to hospital competition [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Public relations pressure to be seen as &#8220;taking action&#8221; [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Regulatory requirements [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Provision of state-sponsored training related to OUD medication [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Interdepartmental collaboration [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Electronic medical record order sets, provider reminders, custom forms, report generation [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Dedicated staff for overdose reporting [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Local expertise in addiction medicine [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Provider knowledge about OUD and comfort with initiation of OUD medication [<xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Technical assistance [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Securing a supply of naloxone kits for dispensing at no cost to the patient [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Leverage the availability of a nonphysician health care provider to provide naloxone education to patients [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Protocols for screening patients for naloxone eligibility [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Local champions in emergency medicine, social work, psychiatry [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Outsourced bilingual health educators who provide direct patient services, record keeping, and information transfer to physicians and nurses [<xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>Provider-Patient Communication: Reported Barriers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Difficulty maintaining contact with providers [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Lack of privacy within the ED made patient discussions challenging [<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Difficulty communicating with patient due to language, comprehension, intoxication, and/or altered conscious state [<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; The clients are more likely than others to miss appointments and can be less motivated to reach their full physical potential [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Discussing naloxone in a way that encourages patients to buy in [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Providers concerned about offending their patients about the cost of naloxone [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Patient dishonesty [<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>Provider-Patient Communication: Reported Enablers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Greater involvement of family members in care/treatment plans and addiction education with nurses and other health care providers [<xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Open discussions with patient and family [<xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>]</td></tr><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>Patient Perceptions: Reported Barriers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Patient apprehension in discussing substance use with HCPs [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Patient distrust of healthcare services [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Patient fear of being stigmatized by HCPs [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Lack of trust that the hospital SCS would provide adequate protection from criminalization and surveillance [<xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>Patient Perceptions: Reported Enablers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Increased patient awareness of high risk alcohol consumption [<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>Provider Perceptions: Reported Barriers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Doubt related to policy changes efficacy, screening/treatment efficacy and patient adherence [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; The perception that psychosocial interventions are not the responsibility of ED HCPs [<xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; HCP resistance to changes in practice [<xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; HCP resistance due to belief that they are encouraging drug use and increasing harms [<xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; HCPs bias and stigma toward drug using patients [<xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Lack of understanding of who would benefit from naloxone kits [<xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Difficulty motivating HCPs to buy in [<xref rid="pone.0294804.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; HCP opposition to harm reduction strategies and associated resource allocation [<xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" style="background-color:#E7E6E6" rowspan="1" colspan="1">
<bold>Provider Perceptions: Reported Enablers of Implementation</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Belief in effectiveness of policy changes [<xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Increased provider awareness of high risk alcohol consumption [<xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Staff acceptance [<xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>]</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec022"><title>Quality appraisal</title><p>Overall the quality of the included studies was moderate to high with 2% (n = 1) [<xref rid="pone.0294804.ref066" ref-type="bibr">66</xref>] scoring 0, 3% (n = 2) [<xref rid="pone.0294804.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0294804.ref070" ref-type="bibr">70</xref>] scoring 1, 8% (n = 5) [<xref rid="pone.0294804.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0294804.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0294804.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0294804.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0294804.ref072" ref-type="bibr">72</xref>] scoring 2, 36% (n = 21) [<xref rid="pone.0294804.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0294804.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0294804.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0294804.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0294804.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0294804.ref050" ref-type="bibr">50</xref>, <xref rid="pone.0294804.ref053" ref-type="bibr">53</xref>, <xref rid="pone.0294804.ref056" ref-type="bibr">56</xref>&#8211;<xref rid="pone.0294804.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0294804.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0294804.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0294804.ref069" ref-type="bibr">69</xref>, <xref rid="pone.0294804.ref074" ref-type="bibr">74</xref>, <xref rid="pone.0294804.ref077" ref-type="bibr">77</xref>, <xref rid="pone.0294804.ref079" ref-type="bibr">79</xref>, <xref rid="pone.0294804.ref080" ref-type="bibr">80</xref>] scoring 3, 29% (n = 17) [<xref rid="pone.0294804.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0294804.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0294804.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0294804.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0294804.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0294804.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0294804.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0294804.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0294804.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0294804.ref047" ref-type="bibr">47</xref>&#8211;<xref rid="pone.0294804.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0294804.ref054" ref-type="bibr">54</xref>, <xref rid="pone.0294804.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0294804.ref075" ref-type="bibr">75</xref>, <xref rid="pone.0294804.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0294804.ref081" ref-type="bibr">81</xref>] scoring 4, and 22% (n = 13) [<xref rid="pone.0294804.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0294804.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0294804.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0294804.ref040" ref-type="bibr">40</xref>&#8211;<xref rid="pone.0294804.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0294804.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0294804.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0294804.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0294804.ref067" ref-type="bibr">67</xref>, <xref rid="pone.0294804.ref068" ref-type="bibr">68</xref>, <xref rid="pone.0294804.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0294804.ref078" ref-type="bibr">78</xref>] scoring 5 (<xref rid="pone.0294804.t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec023"><title>Partner reflections on gaps in the literature</title><p>The following provides additional reflections from our patient and decision maker community partners on gaps identified through our review (<xref rid="pone.0294804.t005" ref-type="table">Table 5</xref>). This section aims to share further contextual details that may be useful to researchers and policy makers. Consultations with partners took place after the preliminary data chart was developed.</p><table-wrap position="float" id="pone.0294804.t005" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0294804.t005</object-id><label>Table 5</label><caption><title>Summary of partner reflections on gaps in the literature.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0294804.t005g" position="float" orientation="portrait" xlink:href="pone.0294804.t005.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Summary of Partner Reflections on Gaps in the Literature</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#8226; Using trauma-informed approaches to guide the design and implementation of harm reduction strategies should be considered.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; PWUAD can experience trauma through interacting with health services and they share these experiences with their peers. Creating and/or improving programs that allow for the reporting of neglect or abuse could help establish greater trust between PWUAD and providers and help improve issues related to accountability.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Providing education related to safe use of all drugs, not just opioids should be considered when developing harm reduction strategies.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Providing education to providers on the varied types of drug/alcohol patients may be using and providing education on best practices on how to interact with people who use drugs/alcohol should be considered.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Treatment referrals are viewed as valuable, but these services can be located away from hospitals, and transit to and from these locations can be viewed as a significant barrier.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; When interacting with healthcare institutions PWUAD can feel like they must critically consider treatment recommendations before they follow them because they may feel that they know more about safe drug use than providers.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; PWUAD often have strong networks and information about safe use practices are often shared within communities. These networks have the potential to be a valuable information sharing resource.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Future research should consider including PWUAD in the design and implementation of these programs.</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Strategies to deal with adverse events, such as allergic reactions to Naloxone or methadone, should be planned for and integrated into harm reduction programs.</td></tr></tbody></table></alternatives></table-wrap></sec></sec><sec sec-type="conclusions" id="sec024"><title>Discussion</title><p>Overall, this review identified a diverse range of harm reduction strategies, which had been evaluated and implemented in different types of acute health care settings. Strategies were primarily implemented in the ED, followed by a range of inpatient settings such as general medicine, rehabilitation, critical care, and mental health or pain teams. The identified outcome measures used for strategy evaluation were related to safe use, managed use and use itself. Finally, the included studies did not report detailed implementation strategies or the use of frameworks to guide implementation. Factors related to implementation were inconsistently reported across articles, however a range of barriers and enablers were reported, albeit primarily related to system and organizational level factors.</p><p>Our findings suggest that there is a growing interest in the implementation of harm reduction strategies within acute care settings, as publications on this subject have dramatically increased within the last three years. While EDs have typically not considered such programs to be part of their mandate, calls for the use of harm reduction strategies within EDs have begun to emerge [<xref rid="pone.0294804.ref084" ref-type="bibr">84</xref>&#8211;<xref rid="pone.0294804.ref086" ref-type="bibr">86</xref>]. This apparent willingness to implement such strategies in ED settings is promising for the success of future projects, particularly given that PWUD seeking health care are more likely to do so via EDs [<xref rid="pone.0294804.ref087" ref-type="bibr">87</xref>]. However, while there appears to be growing support within EDs, we identified a limited number of studies which were set in non-mental health inpatient units. Training and harm reduction programs within these health service settings have the potential to be a valuable resource and reduce stigma. As such, further research exploring implementing programs in non-mental health inpatient settings are needed.</p><p>While this review identified a diverse range of harm reduction strategies, additional strategies currently being used in other settings were notably absent. Managing and providing nutrition for PWUAD [<xref rid="pone.0294804.ref088" ref-type="bibr">88</xref>], providing housing resources [<xref rid="pone.0294804.ref089" ref-type="bibr">89</xref>], drug checking technology to allow PWUAD to ascertain unknown chemicals in their street drugs [<xref rid="pone.0294804.ref090" ref-type="bibr">90</xref>, <xref rid="pone.0294804.ref091" ref-type="bibr">91</xref>], and providing off label prescriptions (i.e., safe supply) to PWUAD [<xref rid="pone.0294804.ref092" ref-type="bibr">92</xref>] are all increasingly being considered as important harm reduction approaches, yet to our knowledge they have not been evaluated for use in EDs and/or inpatient settings. Additionally, our patient partners noted that providing education to PWUAD that improves their understanding of the health services they access could help set appropriate expectations on what kind of care they can expect to receive, potentially mitigating instances of leaving against medical advice and/or distrust of HCPs and health services. In the context of other healthcare services, educational strategies focused on health literacy have been shown to strengthen patient engagement [<xref rid="pone.0294804.ref093" ref-type="bibr">93</xref>] and improve patient health outcomes [<xref rid="pone.0294804.ref094" ref-type="bibr">94</xref>] and should therefore be considered as a potential avenue for additional harm reduction approaches.</p><p>Most outcome measures included in this review were designed to capture data related to program uptake, adherence and real world efficacy. As such, these outcome measures have the potential to inform the allocation of program resources and the tailoring of programs to specific contexts, making them valuable in informing program implementation, program evaluation and quality improvement projects. Of note, measurement of the satisfaction/experience of care was utilized in only 22% (n = 13) of the included studies. PWUAD dissatisfaction and poor experiences of care has been associated with stigma related to drug use, and this type of stigma has been identified as a factor in increased risk of leaving against medical advice and poor health outcomes [<xref rid="pone.0294804.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0294804.ref095" ref-type="bibr">95</xref>]. Additionally, abuse and suffering experienced as a result of accessing healthcare is more likely among stigmatized populations, is poorly understood and often goes unreported [<xref rid="pone.0294804.ref096" ref-type="bibr">96</xref>]. Measures of satisfaction or experience of care which are patient-oriented could be a valuable tool in widening our understanding of and managing these issues during program implementation and evaluation, potentially leading to improved patient outcomes.</p><p>While there were studies included in this review that reported implementation factors related to communication and marketing, cost, quality and performance, sustainability, and provider training, none of the studies utilized validated frameworks to inform their approach to implementation. Given the myriad of factors that can influence effective implementation [<xref rid="pone.0294804.ref097" ref-type="bibr">97</xref>] (e.g., rural/urban setting, available resources, level of personnel training, and patient/provider beliefs and attitudes) a greater emphasis on developing implementation strategies prior to implementation could help improve the effectiveness of approaches. This review also identified a range of barriers and enablers to implementation, most of which related to system and organizational level factors. Absent from these barriers and enablers was public awareness and opinion of harm reduction approaches. Negative public opinion of PWUAD and of harm reduction strategies can negatively impact the perceived value of certain strategies [<xref rid="pone.0294804.ref098" ref-type="bibr">98</xref>]. Media reporting of harm reduction services has the potential to reduce stigma against PWUAD and increase acceptance of harm reduction approaches [<xref rid="pone.0294804.ref099" ref-type="bibr">99</xref>]. In settings where HCP buy-in is a barrier, utilizing public messaging and information campaigns of the benefits of harm reduction services could help improve uptake by HCPs.</p><sec id="sec025"><title>Limitations</title><p>We included studies based on our definition of a harm reduction approach. Harm reduction is a broad philosophy encompassing a range of ideas and as such our definition may have limited the inclusion of some approaches. However, our team included a harm reduction specialist who was consulted throughout the process to ensure that we were comprehensive in our inclusion of approaches. This review sought to identify and describe the scope of the available literature and as such providing definitive recommendations related to the implementation and/or evaluation of specific programs was not possible. Further, this review is not a meta-analysis and as such, the generalizability of the results within each study was not assessed. Our approach to data synthesis involved coding extracted data into validated frameworks (e.g., Hawk&#8217;s harm reduction principles), this process involved some level of subjective interpretation. To mitigate these effects, coding was done independently by two reviewers who then resolved any discrepancies through consensus or consultation with the research team. Our partners were engaged throughout this review to help contextualize our findings and ensure that we maintained a patient-centered approach in our methodology and reporting. Partner reflections should only be considered as potential avenues for future research and not definitive conclusions.</p></sec></sec><sec sec-type="conclusions" id="sec026"><title>Conclusion</title><p>This scoping review sought to map and describe drug and alcohol-related harm reduction strategies, which have been evaluated in inpatient settings and EDs, the outcome measures used to evaluate these strategies, and implementation characteristics. We identified several gaps in the types and targets of potentially beneficial strategies, outcome measures, and factors related to the implementation of harm reduction strategies for PWUAD. Patient partners provided valuable insight throughout the review process to enrich study findings. The findings of this review may inform future research and will serve as a resource for harm reduction evaluation and implementation efforts in the context of EDs and inpatient settings.</p></sec><sec id="sec027" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0294804.s001" position="float" content-type="local-data" orientation="portrait"><label>S1 Table</label><caption><title>Search strategy.</title><p>(XLSX)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0294804.s001.xlsx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="pone.0294804.s002" position="float" content-type="local-data" orientation="portrait"><label>S2 Table</label><caption><title>The Preferred Reporting Items for Systematic Reviews and Meta-analyses for Scoping Reviews checklist.</title><p>JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews.* Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web sites.&#8224; A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources (see first footnote). &#8225; The frameworks by Arksey and O&#8217;Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping review as data charting.&#167; The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document) [<xref rid="pone.0294804.ref019" ref-type="bibr">19</xref>].</p><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0294804.s002.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="pone.0294804.s003" position="float" content-type="local-data" orientation="portrait"><label>S3 Table</label><caption><title>The Guidance for Reporting Involvement of Patients and the Public revised short form (GRIPP2-SF) checklist [<xref rid="pone.0294804.ref021" ref-type="bibr">21</xref>].</title><p>(DOCX)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0294804.s003.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to acknowledge the support of our research team, specifically Sharon Amey for her work on this project. We would like to thank our partners, Morgan Joudrey, Amanda Hudson-Frigault, Lesley Huska and Caroline Jose. We would also like to acknowledge the Nova Scotia Health Authority, IWK Health, St Michael&#8217;s Hospital, the Toronto Opioid Action Network Implementation Committee and the Strategy for Patient-Oriented Research Evidence Alliance for their support of this project.</p></ack><ref-list><title>References</title><ref id="pone.0294804.ref001"><label>1</label><mixed-citation publication-type="book"><collab>Atlas on substance use</collab> (<year>2010</year>): <source>resources for the prevention and treatment of substance use disorders.</source><publisher-name>World Health Organization</publisher-name>; 2010 p. <fpage>137</fpage>. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/44455/9789241500616_eng.pdf" ext-link-type="uri">https://apps.who.int/iris/bitstream/handle/10665/44455/9789241500616_eng.pdf</ext-link></mixed-citation></ref><ref id="pone.0294804.ref002"><label>2</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McNeil</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kerr</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Pauly</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Small</surname><given-names>W</given-names></name>. <article-title>Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.</article-title><source>Addiction.</source><year>2016</year>;<volume>111</volume>: <fpage>685</fpage>&#8211;<lpage>694</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/add.13214</pub-id><pub-id pub-id-type="pmid">26498577</pub-id><pub-id pub-id-type="pmcid">PMC4801725</pub-id></mixed-citation></ref><ref id="pone.0294804.ref003"><label>3</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Palepu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tyndall</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Leon</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>J</given-names></name>, <name name-style="western"><surname>O&#8217;Shaughnessy</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Schechter</surname><given-names>MT</given-names></name>, <etal>et al</etal>. <article-title>Hospital utilization and costs in a cohort of injection drug users.</article-title><source>CMAJ.</source><year>2001</year>;<volume>165</volume>: <fpage>415</fpage>&#8211;<lpage>420</lpage>. <pub-id pub-id-type="pmid">11531049</pub-id><pub-id pub-id-type="pmcid">PMC81365</pub-id></mixed-citation></ref><ref id="pone.0294804.ref004"><label>4</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ali</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nafeh</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Rehm</surname><given-names>J</given-names></name>, <name name-style="western"><surname>LeBlanc</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Elton-Marshall</surname><given-names>T</given-names></name>. <article-title>Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.</article-title><source>International Journal of Drug Policy</source>. <year>2021</year>;<volume>93</volume>: <fpage>103237</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugpo.2021.103237</pub-id><pub-id pub-id-type="pmid">33893026</pub-id><pub-id pub-id-type="pmcid">PMC9759688</pub-id></mixed-citation></ref><ref id="pone.0294804.ref005"><label>5</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Russell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nafeh</surname><given-names>F</given-names></name>, <name name-style="western"><surname>LeBlanc</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Imtiaz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Elton-Marshall</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.</article-title><source>BMC Public Health</source>. <year>2021</year>;<volume>21</volume>: <fpage>2021</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12889-021-12104-w</pub-id><pub-id pub-id-type="pmid">34742267</pub-id><pub-id pub-id-type="pmcid">PMC8571863</pub-id></mixed-citation></ref><ref id="pone.0294804.ref006"><label>6</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chan Carusone</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Guta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>C</given-names></name>, <name name-style="western"><surname>O&#8217;Leary</surname><given-names>B</given-names></name>, <etal>et al</etal>. &#8220;<article-title>Maybe if I stop the drugs, then maybe they&#8217;d care?&#8221;-hospital care experiences of people who use drugs.</article-title><source>Harm Reduct J</source>. <year>2019</year>;<volume>16</volume>: <fpage>16</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12954-019-0285-7</pub-id><pub-id pub-id-type="pmid">30760261</pub-id><pub-id pub-id-type="pmcid">PMC6373073</pub-id></mixed-citation></ref><ref id="pone.0294804.ref007"><label>7</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lenton</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Single</surname><given-names>E</given-names></name>. <article-title>The definition of harm reduction</article-title>. <source>Drug Alcohol Rev</source>. <year>1998</year>;<volume>17</volume>: <fpage>213</fpage>&#8211;<lpage>219</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/09595239800187011</pub-id><pub-id pub-id-type="pmid">16203486</pub-id></mixed-citation></ref><ref id="pone.0294804.ref008"><label>8</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dietze</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gerra</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Poznyak</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Campello</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kashino</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Dzhonbekov</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>An observational prospective cohort study of naloxone use at witnessed overdoses, Kazakhstan, Kyrgyzstan, Tajikistan, Ukraine</article-title>. <source>Bull World Health Organ</source>. <year>2022</year>;<volume>100</volume>: <fpage>187</fpage>&#8211;<lpage>195</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2471/BLT.21.286459</pub-id><pub-id pub-id-type="pmid">35261407</pub-id><pub-id pub-id-type="pmcid">PMC8886259</pub-id></mixed-citation></ref><ref id="pone.0294804.ref009"><label>9</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wodak</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maher</surname><given-names>L</given-names></name>. <article-title>The effectiveness of harm reduction in preventing HIV among injecting drug users.</article-title><source>N S W Public Health Bull</source>. <year>2010</year>;<volume>21</volume>: <fpage>69</fpage>&#8211;<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1071/NB10007</pub-id><pub-id pub-id-type="pmid">20513304</pub-id></mixed-citation></ref><ref id="pone.0294804.ref010"><label>10</label><mixed-citation publication-type="journal"><collab>American College of Emergency Physicians Applauds Removal of X-waiver</collab>, <article-title>Expanding Medication-assisted Treatment for Opioid Use Disorder</article-title>. <source>Targeted News Service.</source><day>15</day><month>Jan</month><year>2021</year>. <source>Available</source>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.proquest.com/docview/2477988229/citation/8F19DDC71BA540EFPQ/1" ext-link-type="uri">http://www.proquest.com/docview/2477988229/citation/8F19DDC71BA540EFPQ/1</ext-link>. Accessed 30 Apr 2023.</mixed-citation></ref><ref id="pone.0294804.ref011"><label>11</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rachlis</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Kerr</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Montaner</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>E</given-names></name>. <article-title>Harm reduction in hospitals: is it time?</article-title><source>Harm Reduction Journal</source>. <year>2009</year>;<volume>6</volume>: <fpage>19</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1477-7517-6-19</pub-id><pub-id pub-id-type="pmid">19638238</pub-id><pub-id pub-id-type="pmcid">PMC2731094</pub-id></mixed-citation></ref><ref id="pone.0294804.ref012"><label>12</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kendall</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Mark</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Boyd</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada.</article-title><source>Harm Reduct J</source>. <year>2017</year>;<volume>14</volume>: <fpage>16</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12954-017-0143-4</pub-id><pub-id pub-id-type="pmid">28494791</pub-id><pub-id pub-id-type="pmcid">PMC5427560</pub-id></mixed-citation></ref><ref id="pone.0294804.ref013"><label>13</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Merrill</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Deyo</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Marlatt</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Bradley</surname><given-names>KA</given-names></name>. <article-title>Mutual mistrust in the medical care of drug users</article-title>. <source>J GEN INTERN MED</source>. <year>2002</year>;<volume>17</volume>: <fpage>327</fpage>&#8211;<lpage>333</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11606-002-0034-5</pub-id><pub-id pub-id-type="pmid">12047728</pub-id><pub-id pub-id-type="pmcid">PMC1495051</pub-id></mixed-citation></ref><ref id="pone.0294804.ref014"><label>14</label><mixed-citation publication-type="book"><name name-style="western"><surname>Aromataris</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Munn</surname><given-names>Z</given-names></name>, editors. <source>JBI Manual for Evidence Synthesis</source>. <publisher-name>JBI</publisher-name>; <year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.46658/JBIMES-20-01</pub-id></mixed-citation></ref><ref id="pone.0294804.ref015"><label>15</label><mixed-citation publication-type="journal"><collab>Government of Canada CI of HR</collab>. <source>Guide to Knowledge Translation Planning at CIHR: Integrated and End-of-Grant Approaches&#8212;CIHR.</source><day>6</day><month>Dec</month><year>2012</year> [cited 7 Jul 2021]. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cihr-irsc.gc.ca/e/45321.html" ext-link-type="uri">https://cihr-irsc.gc.ca/e/45321.html</ext-link></mixed-citation></ref><ref id="pone.0294804.ref016"><label>16</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Curran</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Somerville</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Boulos</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Caudarella</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Crowther</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Identifying harm reduction strategies for alcohol and drug-use in inpatient care settings and emergency departments: a scoping review protocol</article-title>. <source>BMJ Open</source>. <year>2021</year>;<volume>11</volume>: <fpage>e055654</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2021-055654</pub-id><pub-id pub-id-type="pmid">34711603</pub-id><pub-id pub-id-type="pmcid">PMC8557290</pub-id></mixed-citation></ref><ref id="pone.0294804.ref017"><label>17</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Godin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Stapleton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kirkpatrick</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Hanning</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Leatherdale</surname><given-names>ST</given-names></name>. <article-title>Applying systematic review search methods to the grey literature: a case study examining guidelines for school-based breakfast programs in Canada.</article-title><source>Systematic Reviews</source>. <year>2015</year>;<volume>4</volume>: <fpage>138</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13643-015-0125-0</pub-id><pub-id pub-id-type="pmid">26494010</pub-id><pub-id pub-id-type="pmcid">PMC4619264</pub-id></mixed-citation></ref><ref id="pone.0294804.ref018"><label>18</label><mixed-citation publication-type="journal"><collab>Covidence systematic review software</collab>. <source>Melbourne, Australia: Veritas Health Innovation</source>; <year>2021</year>. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.covidence.org" ext-link-type="uri">www.covidence.org</ext-link></mixed-citation></ref><ref id="pone.0294804.ref019"><label>19</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tricco</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Lillie</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zarin</surname><given-names>W</given-names></name>, <name name-style="western"><surname>O&#8217;Brien</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Colquhoun</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Levac</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.</article-title><source>Ann Intern Med</source>. <year>2018</year>;<volume>169</volume>: <fpage>467</fpage>&#8211;<lpage>473</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/M18-0850</pub-id><pub-id pub-id-type="pmid">30178033</pub-id></mixed-citation></ref><ref id="pone.0294804.ref020"><label>20</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hawk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Coulter</surname><given-names>RWS</given-names></name>, <name name-style="western"><surname>Egan</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Fisk</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Tula</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Harm reduction principles for healthcare settings</article-title>. <source>Harm Reduction Journal</source>. <year>2017</year>;<fpage>14</fpage>. http://dx.doi.org.ezproxy.library.dal.ca/10.1186/s12954-017-0196-4<pub-id pub-id-type="pmid">29065896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12954-017-0196-4</pub-id><pub-id pub-id-type="pmcid">PMC5655864</pub-id></mixed-citation></ref><ref id="pone.0294804.ref021"><label>21</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Staniszewska</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brett</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Simera</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Seers</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mockford</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Goodlad</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.</article-title><source>Research Involvement and Engagement</source>. <year>2017</year>;<volume>3</volume>: <fpage>13</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40900-017-0062-2</pub-id><pub-id pub-id-type="pmid">29062538</pub-id><pub-id pub-id-type="pmcid">PMC5611595</pub-id></mixed-citation></ref><ref id="pone.0294804.ref022"><label>22</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hong</surname><given-names>QN</given-names></name>, <name name-style="western"><surname>Pluye</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fabregues</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bartlett</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Boardman</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cargo</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Mixed Methods Appraisal Tool (MMAT) Version 2018: User Guide.</article-title><source>Department of Family Medicine, McGill University</source>; <year>2018</year>. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteria-manual_2018-08-01_ENG.pdf" ext-link-type="uri">http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteria-manual_2018-08-01_ENG.pdf</ext-link></mixed-citation></ref><ref id="pone.0294804.ref023"><label>23</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Brooks HL</surname><given-names>O</given-names></name><name name-style="western"><surname>&#8217;Brien</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Salvalaggio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hyshka</surname><given-names>E</given-names></name>. <article-title>Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs</article-title>. <source>Drug and Alcohol Review</source>. <year>2019</year>;<volume>38</volume>: <fpage>423</fpage>&#8211;<lpage>427</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/dar.12930</pub-id><pub-id pub-id-type="pmid">31021491</pub-id></mixed-citation></ref><ref id="pone.0294804.ref024"><label>24</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Christian</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bottner</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Baysinger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boulton</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Valencia</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Hospital Buprenorphine Program for Opioid Use Disorder Is Associated With Increased Inpatient and Outpatient Addiction Treatment</article-title>. <source>Journal of Hospital Medicine</source>. <year>2021</year>;<volume>16</volume>: <fpage>345</fpage>&#8211;<lpage>348</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.12788/jhm.3591</pub-id><pub-id pub-id-type="pmid">34129485</pub-id><pub-id pub-id-type="pmcid">PMC8191768</pub-id></mixed-citation></ref><ref id="pone.0294804.ref025"><label>25</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Devries</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rafie</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ajayi</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Kreshak</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Edmonds</surname><given-names>KP</given-names></name>. <article-title>Results of a Naloxone Screening Quality-Improvement Project in an Academic Emergency Department.</article-title><source>The Journal of Emergency Medicine</source>. <year>2019</year>;<volume>56</volume>: <fpage>378</fpage>&#8211;<lpage>385</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jemermed.2018.12.029</pub-id><pub-id pub-id-type="pmid">30770141</pub-id></mixed-citation></ref><ref id="pone.0294804.ref026"><label>26</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kirby</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Connell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Linneman</surname><given-names>T</given-names></name>. <article-title>Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans</article-title>. <source>American Journal of Health-System Pharmacy</source>. <year>2021</year>;<volume>78</volume>: <fpage>301</fpage>&#8211;<lpage>309</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ajhp/zxaa386</pub-id><pub-id pub-id-type="pmid">33289022</pub-id></mixed-citation></ref><ref id="pone.0294804.ref027"><label>27</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Papp</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vallabhaneni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Morales</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schrock</surname><given-names>JW</given-names></name>. <article-title>Take -home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death- a pilot study.</article-title><source>BMC Health Services Research</source>. <year>2019</year>;<volume>19</volume>: <fpage>957</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12913-019-4734-5</pub-id><pub-id pub-id-type="pmid">31829228</pub-id><pub-id pub-id-type="pmcid">PMC6907348</pub-id></mixed-citation></ref><ref id="pone.0294804.ref028"><label>28</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Prach</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Clancy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>LeBlanc</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Thomasian</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hogan</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Implementation and evaluation of an inpatient naloxone program in a community teaching hospital.</article-title><source>Research in Social and Administrative Pharmacy</source>. <year>2019</year>;<volume>15</volume>: <fpage>1037</fpage>&#8211;<lpage>1042</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.sapharm.2018.10.004</pub-id><pub-id pub-id-type="pmid">30337179</pub-id></mixed-citation></ref><ref id="pone.0294804.ref029"><label>29</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ray</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Waite</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Spexarth</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Korman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Berget</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kodali</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Addiction Management in Hospitalized Patients With Intravenous Drug Use&#8211;Associated Infective Endocarditis.</article-title><source>Psychosomatics</source>. <year>2020</year>;<volume>61</volume>: <fpage>678</fpage>&#8211;<lpage>687</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.psym.2020.06.019</pub-id><pub-id pub-id-type="pmid">32778422</pub-id></mixed-citation></ref><ref id="pone.0294804.ref030"><label>30</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Samuels</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Baird</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Mello</surname><given-names>MJ</given-names></name>. <article-title>Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program.</article-title><source>Academic Emergency Medicine.</source><year>2019</year>;<volume>26</volume>: <fpage>160</fpage>&#8211;<lpage>173</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/acem.13545</pub-id><pub-id pub-id-type="pmid">30074673</pub-id></mixed-citation></ref><ref id="pone.0294804.ref031"><label>31</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Samuels</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Wentz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>McCormick</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McDonald</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>BDL</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Rhode Island&#8217;s Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment</article-title>. <source>Annals of Emergency Medicine</source>. <year>2021</year>;<volume>78</volume>: <fpage>68</fpage>&#8211;<lpage>79</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.annemergmed.2021.02.004</pub-id><pub-id pub-id-type="pmid">33865617</pub-id><pub-id pub-id-type="pmcid">PMC9119858</pub-id></mixed-citation></ref><ref id="pone.0294804.ref032"><label>32</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Snyder</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kalmin</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Moulin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goodman-Meza</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Padwa</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program</article-title>. <source>Annals of Emergency Medicine</source>. <year>2021</year>;<volume>78</volume>: <fpage>759</fpage>&#8211;<lpage>772</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.annemergmed.2021.05.024</pub-id><pub-id pub-id-type="pmid">34353655</pub-id></mixed-citation></ref><ref id="pone.0294804.ref033"><label>33</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Thompson</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Faig</surname><given-names>W</given-names></name>, <name name-style="western"><surname>VanKim</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Afshar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Karnik</surname><given-names>NS</given-names></name>. <article-title>Differences in length of stay and discharge destination among patients with substance use disorders: The effect of Substance Use Intervention Team (SUIT) consultation service.</article-title><source>PLOS ONE</source>. <year>2020</year>;<volume>15</volume>: <fpage>e0239761</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0239761</pub-id><pub-id pub-id-type="pmid">33035229</pub-id><pub-id pub-id-type="pmcid">PMC7546454</pub-id></mixed-citation></ref><ref id="pone.0294804.ref034"><label>34</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Townsend</surname><given-names>LN</given-names></name>. <article-title>A Quantitative Analysis of Standardized Screening, Brief Intervention, and Referral to Treatment (SBIRT) in an Emergency Department.</article-title><source>Dissertation Abstracts International Section A: Humanities and Social Sciences</source>. <year>2021</year>.</mixed-citation></ref><ref id="pone.0294804.ref035"><label>35</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Train</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Thapa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pasho</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Acquisto</surname><given-names>NM</given-names></name>. <article-title>Dispensing a Naloxone Kit at Hospital Discharge: A Retrospective QI Project.</article-title><source>AJN The American Journal of Nursing</source>. <year>2020</year>;<volume>120</volume>: <fpage>48</fpage>&#8211;<lpage>52</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/01.NAJ.0000724248.74793.35</pub-id><pub-id pub-id-type="pmid">33214374</pub-id></mixed-citation></ref><ref id="pone.0294804.ref036"><label>36</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weinstein</surname><given-names>ZM</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>D&#8217;Amico</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Forman</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Regan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Yurkovic</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Inpatient addiction consultation and post-discharge 30-day acute care utilization</article-title>. <source>Drug and Alcohol Dependence</source>. <year>2020</year>;<volume>213</volume>: <fpage>108081</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2020.108081</pub-id><pub-id pub-id-type="pmid">32485657</pub-id><pub-id pub-id-type="pmcid">PMC7371521</pub-id></mixed-citation></ref><ref id="pone.0294804.ref037"><label>37</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Banta-Green</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Coffin</surname><given-names>PO</given-names></name>, <name name-style="western"><surname>Merrill</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Sears</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Dunn</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Floyd</surname><given-names>AS</given-names></name>, <etal>et al</etal>. <article-title>Impacts of an opioid overdose prevention intervention delivered subsequent to acute care.</article-title><source>Injury Prevention.</source><year>2019</year>;<volume>25</volume>: <fpage>191</fpage>&#8211;<lpage>198</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/injuryprev-2017-042676</pub-id><pub-id pub-id-type="pmid">29436397</pub-id><pub-id pub-id-type="pmcid">PMC6800078</pub-id></mixed-citation></ref><ref id="pone.0294804.ref038"><label>38</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Byrne</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Merchant</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Baginski</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dumas</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Inpatient link to peer recovery coaching: Results from a pilot randomized control trial</article-title>. <source>Drug and Alcohol Dependence</source>. <year>2020</year>;<volume>215</volume>: <fpage>108234</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2020.108234</pub-id><pub-id pub-id-type="pmid">32891501</pub-id></mixed-citation></ref><ref id="pone.0294804.ref039"><label>39</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cushman</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Liebschutz</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Moreau</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>MD</given-names></name>. <article-title>Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization</article-title>. <source>Journal of Substance Abuse Treatment</source>. <year>2016</year>;<volume>68</volume>: <fpage>68</fpage>&#8211;<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jsat.2016.06.003</pub-id><pub-id pub-id-type="pmid">27431049</pub-id><pub-id pub-id-type="pmcid">PMC5018431</pub-id></mixed-citation></ref><ref id="pone.0294804.ref040"><label>40</label><mixed-citation publication-type="journal"><name name-style="western"><surname>D&#8217;Onofrio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fiellin</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Pantalon</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Chawarski</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Owens</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Degutis</surname><given-names>LC</given-names></name>, <etal>et al</etal>. <article-title>A Brief Intervention Reduces Hazardous and Harmful Drinking in Emergency Department Patients</article-title>. <source>Annals of Emergency Medicine</source>. <year>2012</year>;<volume>60</volume>: <fpage>181</fpage>&#8211;<lpage>192</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.annemergmed.2012.02.006</pub-id><pub-id pub-id-type="pmid">22459448</pub-id><pub-id pub-id-type="pmcid">PMC3811141</pub-id></mixed-citation></ref><ref id="pone.0294804.ref041"><label>41</label><mixed-citation publication-type="journal"><name name-style="western"><surname>D&#8217;Onofrio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pantalon</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Degutis</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Fiellin</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Busch</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Chawarski</surname><given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>Brief Intervention for Hazardous and Harmful Drinkers in the Emergency Department</article-title>. <source>Annals of Emergency Medicine</source>. <year>2008</year>;<volume>51</volume>: <fpage>742</fpage>&#8211;<lpage>750</lpage>.e2. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.annemergmed.2007.11.028</pub-id><pub-id pub-id-type="pmid">18436340</pub-id><pub-id pub-id-type="pmcid">PMC2819119</pub-id></mixed-citation></ref><ref id="pone.0294804.ref042"><label>42</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gryczynski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nordeck</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Welsh</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>O&#8217;Grady</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>RP</given-names></name>. <article-title>Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder</article-title>. <source>Ann Intern Med</source>. <year>2021</year>;<volume>174</volume>: <fpage>899</fpage>&#8211;<lpage>909</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/M20-5475</pub-id><pub-id pub-id-type="pmid">33819055</pub-id></mixed-citation></ref><ref id="pone.0294804.ref043"><label>43</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Joosten</surname><given-names>E a. G</given-names></name>, <name name-style="western"><surname>Jong</surname><given-names>CAJ de</given-names></name>, <name name-style="western"><surname>Oene</surname><given-names>GH de W</given-names></name>, <name name-style="western"><surname>Sensky</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Staak</surname><given-names>CPF van der</given-names></name>. <article-title>Shared Decision-Making Reduces Drug Use and Psychiatric Severity in Substance-Dependent Patients.</article-title><source>PPS</source>. <year>2009</year>;<volume>78</volume>: <fpage>245</fpage>&#8211;<lpage>253</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1159/000219524</pub-id><pub-id pub-id-type="pmid">19468259</pub-id></mixed-citation></ref><ref id="pone.0294804.ref044"><label>44</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Monti</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Colby</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Barnett</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Spirito</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rohsenow</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department.</article-title><source>J Consult Clin Psychol</source>. <year>1999</year>;<volume>67</volume>: <fpage>989</fpage>&#8211;<lpage>994</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037//0022-006x.67.6.989</pub-id><pub-id pub-id-type="pmid">10596521</pub-id></mixed-citation></ref><ref id="pone.0294804.ref045"><label>45</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Stein</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>Herman</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Keosaian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>BJ</given-names></name>, <etal>et al</etal>. <article-title>Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial.</article-title><source>Addiction</source>. <year>2021</year>;<volume>116</volume>: <fpage>1122</fpage>&#8211;<lpage>1130</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/add.15236</pub-id><pub-id pub-id-type="pmid">32830383</pub-id></mixed-citation></ref><ref id="pone.0294804.ref046"><label>46</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tait</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Hulse</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>SI</given-names></name>. <article-title>Effectiveness of a brief-intervention and continuity of care in enhancing attendance for treatment by adolescent substance users</article-title>. <source>Drug Alcohol Depend</source>. <year>2004</year>;<volume>74</volume>: <fpage>289</fpage>&#8211;<lpage>296</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2004.01.003</pub-id><pub-id pub-id-type="pmid">15194207</pub-id></mixed-citation></ref><ref id="pone.0294804.ref047"><label>47</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dwyer</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Walley</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Langlois</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Cromwell</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department.</article-title><source>Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health</source>. <year>2015</year>;<fpage>16</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5811/westjem.2015.2.24909</pub-id><pub-id pub-id-type="pmid">25987910</pub-id><pub-id pub-id-type="pmcid">PMC4427207</pub-id></mixed-citation></ref><ref id="pone.0294804.ref048"><label>48</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Eswaran</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Cruz</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Lank</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name>. <article-title>Development of a take-home naloxone program at an urban academic emergency department</article-title>. <source>Journal of the American Pharmacists Association</source>. <year>2020</year>;<volume>60</volume>: <fpage>e324</fpage>&#8211;<lpage>e331</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.japh.2020.06.017</pub-id><pub-id pub-id-type="pmid">32690447</pub-id></mixed-citation></ref><ref id="pone.0294804.ref049"><label>49</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hurt</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aledhaim</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moayedi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schenkel</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>. <article-title>Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA.</article-title><source>Substance Use &amp; Misuse.</source><year>2020</year>;<volume>55</volume>: <fpage>2237</fpage>&#8211;<lpage>2242</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/10826084.2020.1797811</pub-id><pub-id pub-id-type="pmid">32729772</pub-id></mixed-citation></ref><ref id="pone.0294804.ref050"><label>50</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jakubowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pappas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Isaacsohn</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Castillo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Masyukova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Silvera</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Development and evaluation of a pilot overdose education and naloxone distribution program for hospitalized general medical patients</article-title>. <source>Substance Abuse</source>. <year>2019</year>;<volume>40</volume>: <fpage>61</fpage>&#8211;<lpage>65</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/08897077.2018.1518836</pub-id><pub-id pub-id-type="pmid">30475162</pub-id><pub-id pub-id-type="pmcid">PMC6778336</pub-id></mixed-citation></ref><ref id="pone.0294804.ref051"><label>51</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kestler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Buxton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Meckling</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Giesler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fuller</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Factors Associated With Participation in an Emergency Department&#8211;Based Take-Home Naloxone Program for At-Risk Opioid Users</article-title>. <source>Annals of Emergency Medicine</source>. <year>2017</year>;<volume>69</volume>: <fpage>340</fpage>&#8211;<lpage>346</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.annemergmed.2016.07.027</pub-id><pub-id pub-id-type="pmid">27745764</pub-id></mixed-citation></ref><ref id="pone.0294804.ref052"><label>52</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liebling</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Perez</surname><given-names>JJS</given-names></name>, <name name-style="western"><surname>Litterer</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Greene</surname><given-names>C</given-names></name>. <article-title>Implementing hospital-based peer recovery support services for substance use disorder</article-title>. <source>The American Journal of Drug and Alcohol Abuse</source>. <year>2021</year>;<volume>47</volume>: <fpage>229</fpage>&#8211;<lpage>237</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/00952990.2020.1841218</pub-id><pub-id pub-id-type="pmid">33216634</pub-id></mixed-citation></ref><ref id="pone.0294804.ref053"><label>53</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moore</surname><given-names>PQ</given-names></name>, <name name-style="western"><surname>Cheema</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Celmins</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Follman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Soni</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Point-of-care naloxone distribution in the emergency department: A pilot study</article-title>. <source>American Journal of Health-System Pharmacy</source>. <year>2021</year>;<volume>78</volume>: <fpage>360</fpage>&#8211;<lpage>366</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ajhp/zxaa409</pub-id><pub-id pub-id-type="pmid">33555343</pub-id><pub-id pub-id-type="pmcid">PMC10893849</pub-id></mixed-citation></ref><ref id="pone.0294804.ref054"><label>54</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mullennix</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Iseler</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kwiatkowski</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>McCann-Spry</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Skinner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuhl</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>A Clinical Nurse Specialist&#8211;Led Emergency Department Naloxone Distribution Program.</article-title><source>Clinical Nurse Specialist.</source><year>2020</year>;<volume>34</volume>: <fpage>116</fpage>&#8211;<lpage>123</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/NUR.0000000000000515</pub-id><pub-id pub-id-type="pmid">32250993</pub-id></mixed-citation></ref><ref id="pone.0294804.ref055"><label>55</label><mixed-citation publication-type="journal"><name name-style="western"><surname>O&#8217;Brien</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Dabbs</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Veugelers</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Hyshka</surname><given-names>E</given-names></name>. <article-title>Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.</article-title><source>BMC Health Services Research</source>. <year>2019</year>;<volume>19</volume>: <fpage>632</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12913-019-4469-3</pub-id><pub-id pub-id-type="pmid">31488142</pub-id><pub-id pub-id-type="pmcid">PMC6727417</pub-id></mixed-citation></ref><ref id="pone.0294804.ref056"><label>56</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Heukelom</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Parappilly</surname><given-names>BP</given-names></name>, <name name-style="western"><surname>Magee</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Corse</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fairgrieve</surname><given-names>C</given-names></name> (<article-title>Kit), et al. Exploring Nurses&#8217; Perceptions of a Managed Alcohol Program at an Acute Care Hospital.</article-title><source>Canadian Journal of Addiction</source>. <year>2019</year>;<volume>10</volume>: <fpage>24</fpage>&#8211;<lpage>28</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/CXA.0000000000000044</pub-id></mixed-citation></ref><ref id="pone.0294804.ref057"><label>57</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>J B, Harrison</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ahamad</surname><given-names>K</given-names></name>, <name name-style="western"><surname>S N, Lappalainen</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Implementation of a naloxone distribution program in an inpatient addiction service: A case study</article-title>. <source>CJAM Canadian Journal of Addiction Medicine</source>. <year>2016</year>;<volume>7</volume>: <fpage>22</fpage>&#8211;<lpage>25</lpage>.</mixed-citation></ref><ref id="pone.0294804.ref058"><label>58</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dong</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Brouwer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hyshka</surname><given-names>E</given-names></name>. <article-title>Supervised consumption services for acute care hospital patients.</article-title><source>CMAJ</source>. <year>2020</year>;<volume>192</volume>: <fpage>E476</fpage>&#8211;<lpage>E479</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1503/cmaj.191365</pub-id><pub-id pub-id-type="pmid">32366467</pub-id><pub-id pub-id-type="pmcid">PMC7207181</pub-id></mixed-citation></ref><ref id="pone.0294804.ref059"><label>59</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ladak</surname><given-names>SSJ</given-names></name>, <name name-style="western"><surname>Sapisochin</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Slepian</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>H</given-names></name>. <article-title>The intersection of harm reduction and postoperative care for an illicit fentanyl consumer after major surgery: A case report</article-title>. <source>Canadian Journal of Pain</source>. <year>2021</year>;<volume>5</volume>: <fpage>166</fpage>&#8211;<lpage>171</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/24740527.2021.1952066</pub-id></mixed-citation></ref><ref id="pone.0294804.ref060"><label>60</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schipper</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dekker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>de Haan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>van den Brink</surname><given-names>W</given-names></name>. <article-title>Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series.</article-title><source>J Psychopharmacol.</source><year>2018</year>;<volume>32</volume>: <fpage>353</fpage>&#8211;<lpage>356</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/0269881117735684</pub-id><pub-id pub-id-type="pmid">29039260</pub-id></mixed-citation></ref><ref id="pone.0294804.ref061"><label>61</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schreyer</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Blome</surname><given-names>A</given-names></name>, <name name-style="western"><surname>D&#8217;Orazio</surname><given-names>JL</given-names></name>. <article-title>A Case Report of a Novel Harm Reduction Intervention Used to Detect Opioid Overdose in the Emergency Department.</article-title><source>Clinical Practice and Cases in Emergency Medicine.</source><year>2020</year>;<fpage>4</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5811/cpcem.2020.7.47936</pub-id><pub-id pub-id-type="pmid">33217269</pub-id><pub-id pub-id-type="pmcid">PMC7676791</pub-id></mixed-citation></ref><ref id="pone.0294804.ref062"><label>62</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weinrib</surname><given-names>AZ</given-names></name>, <name name-style="western"><surname>Burns</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Mu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Azam</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Ladak</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>McRae</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>A case report on the treatment of complex chronic pain and opioid dependence by a multidisciplinary transitional pain service using the ACT Matrix and buprenorphine/naloxone</article-title>. <source>JPR</source>. <year>2017</year>;<volume>10</volume>: <fpage>747</fpage>&#8211;<lpage>755</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2147/JPR.S124566</pub-id><pub-id pub-id-type="pmid">28392713</pub-id><pub-id pub-id-type="pmcid">PMC5376151</pub-id></mixed-citation></ref><ref id="pone.0294804.ref063"><label>63</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Welch</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Jeffers</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Paone</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kunins</surname><given-names>HV</given-names></name>. <article-title>Relay: A Peer-Delivered Emergency Department&#8211;Based Response to Nonfatal Opioid Overdose.</article-title><source>Am J Public Health.</source><year>2019</year>;<volume>109</volume>: <fpage>1392</fpage>&#8211;<lpage>1395</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2105/AJPH.2019.305202</pub-id><pub-id pub-id-type="pmid">31415200</pub-id><pub-id pub-id-type="pmcid">PMC6727316</pub-id></mixed-citation></ref><ref id="pone.0294804.ref064"><label>64</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Young</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Fish</surname><given-names>WW</given-names></name>, <name name-style="western"><surname>Browne</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lawrie</surname><given-names>RS</given-names></name>. <article-title>Using a harm reduction approach with clients who have alcohol/drug dependencies in a spinal cord rehabilitation program</article-title>. <source>J Spinal Cord Med</source>. <year>2002</year>;<volume>25</volume>: <fpage>81</fpage>&#8211;<lpage>87</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/10790268.2002.11753606</pub-id><pub-id pub-id-type="pmid">12137221</pub-id></mixed-citation></ref><ref id="pone.0294804.ref065"><label>65</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Young</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ahamad</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fairbairn</surname><given-names>N</given-names></name>. <article-title>Leaving Hospital Against Medical Advice After Methadone Discontinuation in the Intensive Care Unit: A Case Report.</article-title><source>Canadian Journal of Addiction</source>. <year>2018</year>;<volume>9</volume>: <fpage>34</fpage>&#8211;<lpage>37</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/CXA.0000000000000010</pub-id></mixed-citation></ref><ref id="pone.0294804.ref066"><label>66</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Eswaran</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Bottari</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Splawski</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Bains</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aks</surname><given-names>SE</given-names></name>, <etal>et al</etal>. <article-title>Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals</article-title>. <source>Annals of Emergency Medicine</source>. <year>2020</year>;<volume>76</volume>: <fpage>318</fpage>&#8211;<lpage>327</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.annemergmed.2020.02.013</pub-id><pub-id pub-id-type="pmid">32241746</pub-id></mixed-citation></ref><ref id="pone.0294804.ref067"><label>67</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kosteniuk</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Salvalaggio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>McNeil</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Twan</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>&#8220;You don&#8217;t have to squirrel away in a staircase&#8221;: Patient motivations for attending a novel supervised drug consumption service in acute care.</article-title><source>International Journal of Drug Policy</source>. <year>2021</year>;<volume>96</volume>: <fpage>103275</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugpo.2021.103275</pub-id><pub-id pub-id-type="pmid">34020865</pub-id></mixed-citation></ref><ref id="pone.0294804.ref068"><label>68</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Parappilly</surname><given-names>BP</given-names></name>, <name name-style="western"><surname>Garrod</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Longoz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Eligh</surname><given-names>E</given-names></name>, <name name-style="western"><surname>van Heukelom</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fairgrieve</surname><given-names>CK</given-names></name>, <etal>et al</etal>. <article-title>Exploring the experience of inpatients with severe alcohol use disorder on a managed alcohol program (MAP) at St. Paul&#8217;s Hospital</article-title>. <source>Harm Reduction Journal.</source><year>2020</year>;<volume>17</volume>: <fpage>28</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12954-020-00371-6</pub-id><pub-id pub-id-type="pmid">32398062</pub-id><pub-id pub-id-type="pmcid">PMC7216705</pub-id></mixed-citation></ref><ref id="pone.0294804.ref069"><label>69</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weiland</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Dent</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>NK</given-names></name>. <article-title>Emergency clinician-delivered screening and intervention for high-risk alcohol use: A qualitative analysis</article-title>. <source>Emergency Medicine Australasia</source>. <year>2008</year>;<volume>20</volume>: <fpage>129</fpage>&#8211;<lpage>135</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1742-6723.2007.01002.x</pub-id><pub-id pub-id-type="pmid">18377402</pub-id></mixed-citation></ref><ref id="pone.0294804.ref070"><label>70</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Samuels</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>McDonald</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>McCormick</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Koziol</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Alexander-Scott</surname><given-names>N</given-names></name>. <article-title>Emergency Department and Hospital Care for Opioid Use Disorder: Implementation of Statewide Standards in Rhode Island, 2017&#8211;2018.</article-title><source>Am J Public Health.</source><year>2019</year>;<volume>109</volume>: <fpage>263</fpage>&#8211;<lpage>266</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2105/AJPH.2018.304847</pub-id><pub-id pub-id-type="pmid">30571304</pub-id><pub-id pub-id-type="pmcid">PMC6336059</pub-id></mixed-citation></ref><ref id="pone.0294804.ref071"><label>71</label><mixed-citation publication-type="journal"><name name-style="western"><surname>D&#233;sy</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Perhats</surname><given-names>C</given-names></name>. <article-title>Alcohol Screening, Brief Intervention, and Referral in the Emergency Department: An Implementation Study.</article-title><source>Journal of Emergency Nursing.</source><year>2008</year>;<volume>34</volume>: <fpage>11</fpage>&#8211;<lpage>19</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jen.2007.03.019</pub-id><pub-id pub-id-type="pmid">18237661</pub-id></mixed-citation></ref><ref id="pone.0294804.ref072"><label>72</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Holland</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Nath</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Maciejewski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Paek</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dziura</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department&#8211;initiated Buprenorphine for Opioid Use Disorder.</article-title><source>Academic Emergency Medicine.</source><year>2020</year>;<volume>27</volume>: <fpage>753</fpage>&#8211;<lpage>763</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/acem.14002</pub-id><pub-id pub-id-type="pmid">32352206</pub-id><pub-id pub-id-type="pmcid">PMC7496559</pub-id></mixed-citation></ref><ref id="pone.0294804.ref073"><label>73</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Johnson</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Lapomardo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Thibeau</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Altemus</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hunt</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>JC</given-names></name>. <article-title>A Process Evaluation of a Substance Use Brief Intervention for Adolescents in a Psychiatric Inpatient Program.</article-title><source>Subst Abuse.</source><year>2020</year>;<volume>14</volume>: <fpage>1178221820936666</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1178221820936666</pub-id><pub-id pub-id-type="pmid">32647475</pub-id><pub-id pub-id-type="pmcid">PMC7325535</pub-id></mixed-citation></ref><ref id="pone.0294804.ref074"><label>74</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kestler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Giesler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Buxton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Meckling</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hunte</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone</article-title>. <source>Canadian Journal of Emergency Medicine</source>. <year>2019</year>;<volume>21</volume>: <fpage>226</fpage>&#8211;<lpage>234</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/cem.2018.368</pub-id><pub-id pub-id-type="pmid">29789030</pub-id></mixed-citation></ref><ref id="pone.0294804.ref075"><label>75</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Samuels</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Bernstein</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>BDL</given-names></name>, <name name-style="western"><surname>Krieger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Baird</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mello</surname><given-names>MJ</given-names></name>. <article-title>Peer navigation and take-home naloxone for opioid overdose emergency department patients: Preliminary patient outcomes</article-title>. <source>Journal of Substance Abuse Treatment</source>. <year>2018</year>;<volume>94</volume>: <fpage>29</fpage>&#8211;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jsat.2018.07.013</pub-id><pub-id pub-id-type="pmid">30243414</pub-id></mixed-citation></ref><ref id="pone.0294804.ref076"><label>76</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nordqvist</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wilhelm</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lindqvist</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bendtsen</surname><given-names>P</given-names></name>. <article-title>Can screening and simple written advice reduce excessive alcohol consumption among emergency care patients?</article-title><source>Alcohol</source>. <year>2005</year>;<volume>40</volume>: <fpage>401</fpage>&#8211;<lpage>408</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/alcalc/agh175</pub-id><pub-id pub-id-type="pmid">15955776</pub-id></mixed-citation></ref><ref id="pone.0294804.ref077"><label>77</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wakeman</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Metlay</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Herman</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Rigotti</surname><given-names>NA</given-names></name>. <article-title>Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity.</article-title><source>J GEN INTERN MED</source>. <year>2017</year>;<volume>32</volume>: <fpage>909</fpage>&#8211;<lpage>916</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11606-017-4077-z</pub-id><pub-id pub-id-type="pmid">28526932</pub-id><pub-id pub-id-type="pmcid">PMC5515798</pub-id></mixed-citation></ref><ref id="pone.0294804.ref078"><label>78</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gerdtz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yap</surname><given-names>CYL</given-names></name>, <name name-style="western"><surname>Daniel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Knott</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Innes</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Amphetamine-type stimulant use among patients admitted to the emergency department behavioural assessment unit: Screening and referral outcomes</article-title>. <source>International Journal of Mental Health Nursing</source>. <year>2020</year>;<volume>29</volume>: <fpage>796</fpage>&#8211;<lpage>807</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/inm.12710</pub-id><pub-id pub-id-type="pmid">32141682</pub-id></mixed-citation></ref><ref id="pone.0294804.ref079"><label>79</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boora</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Surood</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Coulombe</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Poudel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Agyapong</surname><given-names>VIO</given-names></name>. <article-title>Improving community care for patients discharged from hospital through zone-wide implementation of a seamless care transition policy</article-title>. <source>International Journal for Quality in Health Care</source>. <year>2021</year>;<volume>33</volume>: <fpage>mzab079</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/intqhc/mzab079</pub-id><pub-id pub-id-type="pmid">33963413</pub-id><pub-id pub-id-type="pmcid">PMC8161518</pub-id></mixed-citation></ref><ref id="pone.0294804.ref080"><label>80</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sise</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Sise</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Kelso</surname><given-names>DJ</given-names></name>. <article-title>Implementing screening, brief intervention, and referral for alcohol and drug use: the trauma service perspective</article-title>. <source>J Trauma</source>. <year>2005</year>;<volume>59</volume>: <fpage>S112</fpage>&#8211;<lpage>118</lpage>; discussion S124-133. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/01.ta.0000176045.95492.01</pub-id><pub-id pub-id-type="pmid">16355046</pub-id></mixed-citation></ref><ref id="pone.0294804.ref081"><label>81</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boudreaux</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Haskins</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Harralson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bernstein</surname><given-names>E</given-names></name>. <article-title>The remote brief intervention and referral to treatment model: Development, functionality, acceptability, and feasibility.</article-title><source>Drug and Alcohol Dependence.</source><year>2015</year>;<volume>155</volume>: <fpage>236</fpage>&#8211;<lpage>242</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2015.07.014</pub-id><pub-id pub-id-type="pmid">26297297</pub-id><pub-id pub-id-type="pmcid">PMC4624210</pub-id></mixed-citation></ref><ref id="pone.0294804.ref082"><label>82</label><mixed-citation publication-type="other">Harm Reduction Principles. In: National Harm Reduction Coalition [Internet]. [cited 19 Jul 2022]. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://harmreduction.org/about-us/principles-of-harm-reduction/" ext-link-type="uri">https://harmreduction.org/about-us/principles-of-harm-reduction/</ext-link></mixed-citation></ref><ref id="pone.0294804.ref083"><label>83</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marlatt</surname><given-names>GA</given-names></name>. <article-title>Harm reduction: Come as you are.</article-title><source>Addictive Behaviors.</source><year>1996</year>;<volume>21</volume>: <fpage>779</fpage>&#8211;<lpage>788</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0306-4603(96)00042-1</pub-id><pub-id pub-id-type="pmid">8904943</pub-id></mixed-citation></ref><ref id="pone.0294804.ref084"><label>84</label><mixed-citation publication-type="other">Embracing harm reduction in the emergency department. In: American Medical Association [Internet]. [cited 22 Jun 2022]. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ama-assn.org/delivering-care/overdose-epidemic/embracing-harm-reduction-emergency-department" ext-link-type="uri">https://www.ama-assn.org/delivering-care/overdose-epidemic/embracing-harm-reduction-emergency-department</ext-link></mixed-citation></ref><ref id="pone.0294804.ref085"><label>85</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hobden</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Cunningham</surname><given-names>JA</given-names></name>. <article-title>Barriers to the dissemination of four harm reduction strategies: a survey of addiction treatment providers</article-title> in <source>Ontario. Harm Reduction Journal</source>. <year>2006</year>;<volume>3</volume>: <fpage>35</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1477-7517-3-35</pub-id><pub-id pub-id-type="pmid">17169151</pub-id><pub-id pub-id-type="pmcid">PMC1764412</pub-id></mixed-citation></ref><ref id="pone.0294804.ref086"><label>86</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Strike</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Guta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>O&#8217;Leary</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Illicit drug use while admitted to hospital: Patient and health care provider perspectives.</article-title><source>PLoS One.</source><year>2020</year>;<volume>15</volume>: <fpage>e0229713</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0229713</pub-id><pub-id pub-id-type="pmid">32134973</pub-id><pub-id pub-id-type="pmcid">PMC7058273</pub-id></mixed-citation></ref><ref id="pone.0294804.ref087"><label>87</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jackson</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>McWilliam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Dingwell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dykeman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gahagan</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Key challenges in providing services to people who use drugs: The perspectives of people working in emergency departments and shelters in Atlantic Canada.</article-title><source>Drugs: Education, Prevention and Policy.</source><year>2014</year>;<volume>21</volume>: <fpage>244</fpage>&#8211;<lpage>253</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/09687637.2013.870534</pub-id><pub-id pub-id-type="pmid">24954982</pub-id><pub-id pub-id-type="pmcid">PMC4046876</pub-id></mixed-citation></ref><ref id="pone.0294804.ref088"><label>88</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Miewald</surname><given-names>C</given-names></name>, <name name-style="western"><surname>McCann</surname><given-names>E</given-names></name>, <name name-style="western"><surname>McIntosh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Temenos</surname><given-names>C</given-names></name>. <article-title>Food as harm reduction: barriers, strategies, and opportunities at the intersection of nutrition and drug-related harm.</article-title><source>Critical Public Health.</source><year>2018</year>;<volume>28</volume>: <fpage>586</fpage>&#8211;<lpage>595</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/09581596.2017.1359406</pub-id></mixed-citation></ref><ref id="pone.0294804.ref089"><label>89</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hong</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Brar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fairbairn</surname><given-names>N</given-names></name>. <article-title>Supporting Self-isolation for COVID-19 With &#8220;Risk Mitigation&#8221; Prescribing and Housing Supports for People Who Use Drugs: A Case Report.</article-title><source>J Addict Med.</source><year>2022</year>;<volume>16</volume>: <fpage>592</fpage>&#8211;<lpage>594</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/ADM.0000000000000954</pub-id><pub-id pub-id-type="pmid">35149612</pub-id><pub-id pub-id-type="pmcid">PMC9531921</pub-id></mixed-citation></ref><ref id="pone.0294804.ref090"><label>90</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Green</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McKenzie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Struth</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lucas</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.</article-title><source>Int J Drug Policy</source>. <year>2020</year>;<volume>77</volume>: <fpage>102661</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugpo.2020.102661</pub-id><pub-id pub-id-type="pmid">31951925</pub-id></mixed-citation></ref><ref id="pone.0294804.ref091"><label>91</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Borden</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Saatchi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vandergrift</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Palaty</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lysyshyn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gill</surname><given-names>CG</given-names></name>. <article-title>A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry</article-title>. <source>Drug and Alcohol Review</source>. <year>2022</year>;<volume>41</volume>: <fpage>410</fpage>&#8211;<lpage>418</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/dar.13370</pub-id><pub-id pub-id-type="pmid">34347332</pub-id><pub-id pub-id-type="pmcid">PMC9292878</pub-id></mixed-citation></ref><ref id="pone.0294804.ref092"><label>92</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McNeil</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fleming</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mayer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mansoor</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Betsos</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.</article-title><source>Am J Public Health.</source><year>2022</year>;<volume>112</volume>: <fpage>S151</fpage>&#8211;<lpage>S158</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2105/AJPH.2021.306692</pub-id><pub-id pub-id-type="pmid">35262376</pub-id><pub-id pub-id-type="pmcid">PMC8965179</pub-id></mixed-citation></ref><ref id="pone.0294804.ref093"><label>93</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Coulter</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ellins</surname><given-names>J</given-names></name>. <article-title>Effectiveness of strategies for informing, educating, and involving patients. BMJ</article-title>: <source>British Medical Journal</source>. <year>2007</year>;<volume>335</volume>: <fpage>24</fpage>&#8211;<lpage>27</lpage>.<pub-id pub-id-type="pmid">17615222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.39246.581169.80</pub-id><pub-id pub-id-type="pmcid">PMC1910640</pub-id></mixed-citation></ref><ref id="pone.0294804.ref094"><label>94</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Geboers</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Reijneveld</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Koot</surname><given-names>JAR</given-names></name>, <name name-style="western"><surname>De Winter</surname><given-names>AF</given-names></name>. <article-title>Moving towards a Comprehensive Approach for Health Literacy Interventions: The Development of a Health Literacy Intervention Model.</article-title><source>International Journal of Environmental Research and Public Health</source>. <year>2018</year>;<volume>15</volume>: <fpage>1268</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijerph15061268</pub-id><pub-id pub-id-type="pmid">29914065</pub-id><pub-id pub-id-type="pmcid">PMC6025600</pub-id></mixed-citation></ref><ref id="pone.0294804.ref095"><label>95</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Meyerson</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Kichler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Atkin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Coles</surname><given-names>HB</given-names></name>. <article-title>I don&#8217;t even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019.</article-title><source>International Journal of Drug Policy</source>. <year>2021</year>;<volume>93</volume>: <fpage>103112</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugpo.2021.103112</pub-id><pub-id pub-id-type="pmid">33461838</pub-id></mixed-citation></ref><ref id="pone.0294804.ref096"><label>96</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wijma</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zbikowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Br&#252;ggemann</surname><given-names>AJ</given-names></name>. <article-title>Silence, shame and abuse in health care: theoretical development on basis of an intervention project among staff</article-title>. <source>BMC Medical Education</source>. <year>2016</year>;<volume>16</volume>: <fpage>75</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12909-016-0595-3</pub-id><pub-id pub-id-type="pmid">26922381</pub-id><pub-id pub-id-type="pmcid">PMC4769844</pub-id></mixed-citation></ref><ref id="pone.0294804.ref097"><label>97</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moullin</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Sabater-Hern&#225;ndez</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fernandez-Llimos</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Benrimoj</surname><given-names>SI</given-names></name>. <article-title>A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework.</article-title><source>Health Research Policy and Systems</source>. <year>2015</year>;<volume>13</volume>: <fpage>16</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12961-015-0005-z</pub-id><pub-id pub-id-type="pmid">25885055</pub-id><pub-id pub-id-type="pmcid">PMC4364490</pub-id></mixed-citation></ref><ref id="pone.0294804.ref098"><label>98</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gidman</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Coomber</surname><given-names>R</given-names></name>. <article-title>Contested space in the pharmacy: Public attitudes to pharmacy harm reduction services in the West of Scotland.</article-title><source>Research in Social and Administrative Pharmacy</source>. <year>2014</year>;<volume>10</volume>: <fpage>576</fpage>&#8211;<lpage>587</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.sapharm.2013.07.006</pub-id><pub-id pub-id-type="pmid">24021859</pub-id></mixed-citation></ref><ref id="pone.0294804.ref099"><label>99</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wild</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Koziel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Anderson-Baron</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Asbridge</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Belle-Isle</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Dell</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Public support for harm reduction: A population survey of Canadian adults.</article-title><source>PLOS ONE</source>. <year>2021</year>;<volume>16</volume>: <fpage>e0251860</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0251860</pub-id><pub-id pub-id-type="pmid">34010338</pub-id><pub-id pub-id-type="pmcid">PMC8133460</pub-id></mixed-citation></ref></ref-list></back><sub-article article-type="aggregated-review-documents" id="pone.0294804.r001" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0294804.r001</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ahmed</surname><given-names initials="S">Saeed</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2023 Saeed Ahmed</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Saeed Ahmed</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0294804" id="rel-obj001" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><boxed-text id="pone.0294804.box001" position="float" specific-use="prior_peer_review_unavailable" orientation="portrait"><sec id="sec028"><title>Transfer Alert</title><p>This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.</p></sec></boxed-text><p>
<named-content content-type="letter-date">27 Feb 2023</named-content>
</p><p>PONE-D-22-25311Harm reduction strategies in acute care for people who use alcohol and/or drugs: A scoping reviewPLOS ONE</p><p>Dear Dr. Curran,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#8217;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>Please submit your revised manuscript by 3/24/2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#160;<email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:<list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Saeed Ahmed, MD</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>.</p><p>&#8203;</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>

<bold>Comments to the Author</bold>
</p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>Reviewer #4:&#160;Yes</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>Reviewer #4:&#160;I Don't Know</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#8212;e.g. participant privacy or use of data from a third party&#8212;those must be specified.</p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>Reviewer #4:&#160;Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1:&#160;Yes</p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>Reviewer #4:&#160;Yes</p><p>**********</p><p>5. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1:&#160;Overall, this is a well-written paper about a topic that needs research. The article starts with a clearly identified and relevant research question. The inclusion and exclusion criteria are clearly written. This study does present results of original research and these results have not been published elsewhere. The article is easy to read and offers actionable knowledge that can be addressed by organizations and healthcare providers. The article does appear to meet standards for ethics and adheres to guidelines and standards for data availability.</p><p>Given the ongoing morbidity and mortality caused by substance use, there has been a push to look at novel ways to engage People Who Use Alcohol and/or Drugs (PWUAD). Many of such novel approaches are based in the ER as PWUAD frequently show up there to seek care as they do not have a steady source of income or Insurance (in the USA). Unfortunately, this has also led to some ER physicians and employees developing a stigma against PWUAD. This has been observed by this reviewer on many occasions while talking to MDs not trained in psychiatry. The authors can consider discussing this as a potential motivating factor for healthcare providers reporting a lack of training in addictions as a more palatable reason to refuse providing care. Tackling this stigma is key to increase willingness to implement such strategies mentioned in line 305.</p><p>The authors can consider adding a comment about the recent decision by the DEA to drop the X waiver requirement.</p><p>The authors can also consider providing housing resources as harm reduction strategies being used in other settings mentioned in line 313.</p><p>This article is a great teaching tool to be discussed in schools and residency training programs to ensure healthcare providers are provided education at a stage before they start working as attendings and develop stigma. The authors can consider tabulating the points mentioned from line 354 to 370 as these are great teaching points for a residency program.</p><p>Minor concerns</p><p>Line 22- please consider rephrasing, the current sentence reads awkwardly.</p><p>Line 52- there should be a / in between "and" and "or" like was mentioned in line 21.</p><p>Line 55- the comma can be removed.</p><p>Line 74 and 75- just because PWUAD presents to the hospital and ED at a higher rate does not mean it is an important point of care. It does make the hospital an ideal location where one can approach PWUAD at a time when they are feeling vulnerable and provide them options. This makes line 78 even more relevant.</p><p>Reviewer #2:&#160;Reviewer Comments to Author</p><p>This is an important and ambitious scoping review on an essential topic. I am glad to see a work so ambitious in manuscript. &#160;Scoping reviews &#160;ideally should systematically identify and chart relevant literature that meet predetermined inclusion criteria. I am glad they grey literature was included as well as stakeholder consultation with PWUD. Hospital based harm reduction strategies can be a critical &#8220;touchpoint&#8221; for improving the health of people who use drugs. I congratulate them on this big accomplishment getting this done and it will be an important piece for harm reduction in healthcare settings as resonates with me as a clinician and a researcher.</p><p>The review seeks to outline four major questions and evaluate the literature in this topic area:</p><p>1. What harm reduction strategies have been evaluated to help alleviate negative health outcomes associated with substance use within inpatient settings and EDs?</p><p>2. What are the commonly reported outcome measures used to evaluate harm reduction strategies and their implementation in these settings?</p><p>3. How are harm reduction strategies implemented in inpatient settings and EDs?</p><p>4. What are the reported barriers and enablers to their implementation?</p><p>Specific Comments/clarifications requested</p><p>1.&#160;&#160;&#160;&#160; The inclusion of alcohol interventions is an interesting one. People who use drugs and alcohol as a term is not well known/used, and the inclusion of people who use alcohol certainly can skew/broaden the patient population since the prevalence of alcohol is high. I think the article could do with clarification about the use of this novel term and justifications as to why. Alcohol harm reduction strategies are a relatively newer field and the inclusion of alcohol harm reduction (managed alcohol, BNI, etc) should be explicated.</p><p>2.&#160;&#160;&#160;&#160; I am glad that the study interventions were coded alongside the Hawk principles of harm reduction in healthcare. Certainly some here but appreciate the delineation of the coding process. With some of the harm reduction principle codes, I wonder about the results. i.e. Wakeman et al 2017 multidisciplinary team offering motivational counseling, pharmacotherapy, is that not an example of humanism? Does Dong et al 2020 supervised consumption service intervention not epitomize the principle of autonomy? Etc</p><p>3.&#160;&#160;&#160;&#160; Clarifications: Page 16 table 2 &#8211; what is Nav Star ? Page 10, Table 1. Welch et al. What is &#8220;Relay program&#8221; please explicate for a general audience</p><p>4.&#160;&#160;&#160;&#160; Clarification: Was any of the grey literature included in the final sample?</p><p>5.&#160;&#160;&#160;&#160; Re Table 4: Barriers and Enablers to Implementation</p><p>I found this table difficult to read. There were so many barriers, particularly I the &#8220;system and organizational factors.&#8221; Could this not be further delineated? It might also be useful to identify any barriers and enablers on the same row, i.e. lack of resources, reported enablers &#8220;securing funding&#8221; if possible. Many of the system and organization factors I think could be further coded and organized.</p><p>6.&#160;&#160;&#160;&#160; Discussion could use some re-work and re-organization. Might consider putting partner reflections before the discussion section. Good section on the summary of the key findings in the study, as well as gaps in comparison to the current harm reduction strategies and or previous literature, but would benefit from further explication of research strategies, areas for more rigorous investigation including methods, as well as clinical, policy and research implications. It would be notable to also mention the distinct policy implications of implementation that are not generalizable across the countries included in this scoping review. &#160;</p><p>7.&#160;&#160;&#160;&#160; I feel the partner/stakeholder reflections section is also incomplete. Were these direct quotes from participants at CBOs and or PWUD? They are listed out almost like direct quotes rather than summarized. Can they be summarized or organized differently? Line 364: &#8220;often feel like they must police their own treatment&#8221; (?) unclear what they mean by this. Reads very disorganized/unclear, not as cohesive as the rest of the manuscript</p><p>Reviewer #3:&#160;Congratulation to the authors for your work on an important topic. The manuscript draws up a comprehensive database search to find research papers. However, the manuscript rests on many case reports. Moreover, studies from more than one country are included. This is important because one of the identified factors is organizational limitations. Laws, regulations, organizational structure, work culture, funding, etc., tend to differ in different countries. Also, organization limitation is a vague term and has yet to be defined by the authors. Illicit substance-induced disorders like opiates, amphetamines, marijuana, and alcohol abuse disorders share many socio-economic challenges. Still, many factors may vary, which can impact harm reduction strategies for each illicit substance, such as the level of stigma and the general approach of clinicians toward patients with amphetamine will be different from marijuana. Also, laws about illicit substances vary per country. The laws about other illicit substances within a country can vary, e.g., marijuana.</p><p>Reviewer #4:&#160;Excellent work with this review. You have done remarkable work with this article. Though not easy to conduct study like this you have done phenomeninal work with this.</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#160;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#160;<email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p></body></sub-article><sub-article article-type="author-comment" id="pone.0294804.r002"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0294804.r002</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="editor-report" id="rel-obj002" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0294804"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">3 Aug 2023</named-content>
</p><p>Authors&#8217; Response</p><p>Thank you for this comment. We agree that stigma toward PWUAD by providers is a complex issue which should be addressed. We have highlighted the potential for strategies, such as training, in EDs on line 359-362</p><p>A comment about the X-waiver decision has been added to the introduction (page 3, line 74-77)</p><p>This sentence was amended to include a reference related to providing housing as a harm reduction strategy (page 24, line 366)</p><p>To improve readability the Partner Reflections on Gaps in the Literature section has been placed in a table and has been moved before the discussion. (page 23, line 325-326)</p><p>This sentenced has been amended for clarity (page 2, line 21-23)</p><p>A &#8220;/&#8221; has been added between the &#8220;and&#8221; and &#8220;or&#8221; (page 3, line 57)</p><p>This comma has been removed (page 3, line 59)</p><p>Line 74 and 75 have been amended and the sentence now states that the hospital is an ideal point of care and not an important point of care. (page 3, line 82)</p><p>Authors&#8217; Response</p><p>Thank you for your comment. Based on our review people who use drugs and/or alcohol is not a novel or uncommonly used term. It is common in the field of harm reduction research. Literature using this or similar terms date to at least 2004 and this term has been in use as of 2022. Please refer to this selection of literature for reference:</p><p>&#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1177/02692163211061994" ext-link-type="uri">https://doi.org/10.1177/02692163211061994</ext-link></p><p>&#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1186/s12954-020-00366-3" ext-link-type="uri">https://doi.org/10.1186/s12954-020-00366-3</ext-link></p><p>&#8211; DOI 10.1007/s10461-013-0587-9 </p><p>&#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.biomedcentral.com/1471-2458/12/312" ext-link-type="uri">http://www.biomedcentral.com/1471-2458/12/312</ext-link>
</p><p>&#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1089/10872910050046340" ext-link-type="uri">https://doi.org/10.1089/10872910050046340</ext-link></p><p>Harm reduction strategies for alcohol have been in use and researched as early as 1983. Literature related to this topic also continues to be published. Please refer to this selection of literature for reference:</p><p>&#8211; DOI: 10.1080/09595230600944529</p><p>&#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.drugpo.2006.05.004" ext-link-type="uri">https://doi.org/10.1016/j.drugpo.2006.05.004</ext-link></p><p>&#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1037/a0026397" ext-link-type="uri">https://doi.org/10.1037/a0026397</ext-link></p><p>&#8211; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fpubh.2022.855416" ext-link-type="uri">https://doi.org/10.3389/fpubh.2022.855416</ext-link></p><p>We appreciate that textual coding involves a certain level of subjective interpretation. Our research team attempted to enhance the rigor of our coding by having two reviewers independently code the included studies based on Hawk&#8217;s principles. Discrepancies between codes were brought to the team, who discussed the studies and assessed which code was appropriate based on their knowledge of the included studies and their expertise. However, we acknowledge that this process is not completely objective, and this has been noted as a limitation within the limitation section. (page 25, line 412-414)</p><p>The authors have clarified that the Relay Program (Table 1) and NavStar (Table 2) are the names of harm reduction strategies. The content of these strategies is described in the &#8220;Intervention Content&#8221; column in Table 2 (page 14 and 16).</p><p>No grey literature was included in the final sample. (page 6, line 194-195, and Figure 1).</p><p>The table has been reformatted for clarity and readability. (page 20-22, Table 4)</p><p>We have added further description in the Data synthesis and presentation section within the Methods to clarify meaning related types of barriers and enablers. (page 6, line 166-173) </p><p>To improve clarity and readability the Partner reflections have been tabulated and moved before the discussion section. (page 23, Table 5)</p><p>As mentioned above, the Partner reflections have been tabulated and moved before the discussion section to improve clarity and readability. </p><p>The partner reflections are not direct quotes, but a summary of reflections of our partners. The table has been renamed and several of the statements have been reworded to clarify this. (page 23, Table 5)</p><p>Authors&#8217; Response</p><p>We agree our comprehensive search is a strength of this review. We would agree that organizational limitation is a vague term, and we would like to note that it was not used as a term in this manuscript or any of the included studies. As mentioned above, we amended the Data synthesis and presentation section within the Methods to include a definition of the term system level and organizational factors. (page 6, line 166-173) </p><p>We agree with the reviewer that the quality of a study&#8217;s findings is dependent on its study design and that barriers and enablers to implementation may vary depending on the country where implementation takes place. However, we would like to emphasize that this review provides a summary of the scope of the available literature related to our topic which was captured by our search strategy and our inclusion criteria. This review is not a meta-analysis, and we are not assessing the generalizability of the results of the included papers or the extent to which study design may limit the generalizability of the findings within each study. To clarify this, the limitation section has been amended with a sentence to that effect. (page 25, line 411-412)</p><supplementary-material id="pone.0294804.s004" position="float" content-type="local-data" orientation="portrait"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0294804.s004.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article article-type="aggregated-review-documents" id="pone.0294804.r003" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0294804.r003</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bluthenthal</surname><given-names initials="RN">Ricky N.</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2023 Ricky N. Bluthenthal</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ricky N. Bluthenthal</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="reviewed-article" id="rel-obj003" xml:lang="en" ext-link-type="doi" xlink:href="10.1371/journal.pone.0294804"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">10 Nov 2023</named-content>
</p><p>Harm reduction strategies in acute care for people who use alcohol and/or drugs: A scoping review</p><p>PONE-D-22-25311R1</p><p>Dear Dr. Curran,</p><p>We&#8217;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#8217;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#8217;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.editorialmanager.com/pone/" ext-link-type="uri">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#8217;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p><p>Kind regards,</p><p>Ricky N. Bluthenthal</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments (optional):</p><p>Congratulations on a thorough and important contribution to examining the use of harm reduction strategies in acute care settings. I think the paper should just use the definition of harm reduction described by Hawk as suggested by reviewer 1. I also agree that methadone is not traditionally considered an harm reduction approach (although it is largely used by one many people on methadone). Addressing these two comments and the few other issues identified by reviewers would improve the paper. Also, this review process has taken too long and I want to apologize for this.</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>

<bold>Comments to the Author</bold>
</p><p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the &#8220;Comments to the Author&#8221; section, enter your conflict of interest statement in the &#8220;Confidential to Editor&#8221; section, and submit your "Accept" recommendation.</p><p>Reviewer #2:&#160;(No Response)</p><p>Reviewer #3:&#160;All comments have been addressed</p><p>**********</p><p>2. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>**********</p><p>3. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>**********</p><p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#8212;e.g. participant privacy or use of data from a third party&#8212;those must be specified.</p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>**********</p><p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #2:&#160;Yes</p><p>Reviewer #3:&#160;Yes</p><p>**********</p><p>6. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #2:&#160;Overall this is a significantly improved manuscript and the authors have done well to improve readability and clarity for a paper on a very important subject. I think this is reaching a level where revisions will be appropriate before publication in this journal.</p><p>A couple points:</p><p>1. Line 65: &#8220;Harm reduction is an approach that emphasizes working with people where they are at, rather than focusing solely on drug and alcohol abstinence&#8221;. The citation (7) used a definition of harm reduction that said &#8220;A policy, programme or intervention should only be called harm reduction if, and only if: (1) the primary goal is the reduction of drug-related harm rather than drug use per se; (2) where abstinence-orientatated strategies are included, strategies are also included to reduce the harm for those who continue to use drugs; and (3) strategies are included which aim to demonstrate that, on the balance of probabilities, it is likely to result in a net reduction of drug-related harm.&#8221; Some other definitions of harm reduction might be utilized here for further clarity rather than working with people where they are at, which is vague. Suggestions:</p><p>Harm reduction refers to interventions aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely (Hawk paper).</p><p>The National Harm Reduction Coalition defines harm reduction as &#8220;a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use&#8221;</p><p>2. Line 68: It is controversial to state that MMT is a harm reduction strategy, that might just be considered evidence-based standard of care for treatment of opioid use disorder. Potentially saying low threshold MOUD (?) programs including buprenorphine</p><p>3. Line 70-71: Again, not to be pedantic, but removal of X-waiver for use of MOUD is not necessarily a harm reduction strategy but a treatment strategy aimed at expanding medication for OUD which is certainly necessary. US HHS/SAHMSA has put 4 buckets of responses across these categories: prevention, treatment, harm reduction and recovery supports.</p><p>4. Characteristics outcome measures: (line 262) I believe that these outcome measures and the organization of outcomes into these categories within harm reduction are a bit shoe-horned and potentially not the right category for analysis. The safer use outcomes seem clear. In my understanding of managed use, in harm reduction, this is a strategy utilized by programs or patients to control and moderate substance use, such as managed alcohol programs during COVID in shelters or housing programs. Therefore, saying that &#8220;managed use was compromised of outcome measures related to referral to/and or acceptance of care, satisfaction and/or experience of care and HCP follow-up&#8221; seems an inappropriate outcome measure category, which might be better expressed as healthcare utilization and engagement or satisfaction. In addition, conditions of use and use itself to me include harm reduction strategies such as use of sterile syringes, using with naloxone, not using alone, etc. I think stating that &#8220;conditions of use and use itself included measures related to mortality, readmission rates, leaving against medical advice, adverse events, length of stay and frequency of drug and/or alcohol&#8221; is perhaps a not a good way to categorize these outcomes, which might be other variables of healthcare utilization.</p><p>5. Table 4: &#8220;difficulty scheduling or locating patients for training&#8221; had no citation paper</p><p>- What is MAP (56)</p><p>- System and Organizational Factors: Reported Enablers of Implementation move to the next page for readability</p><p>- Outsourcing SBIR to whom (80)</p><p>6. Partner reflections: clarify regarding &#8220;reporting of neglect or abuse&#8221; (is that by HCP)? Healthcare worker abuse or neglect (?).</p><p>- Strategies to deal with adverse events such as allergic reactions (to any medication, not just naloxone or methadone)? Perhaps it is stigmatizing to call these two medications out in particular and should just be left broadly as allergic reactions or adverse side events</p><p>Reviewer #3:&#160;Authors have addressed prior concerns noted by all reviewers. Line 360, authors should give examples of organizational level factors. Harm reduction strategies are different for alcohol and illicit substances. Also, systemic barriers as well as laws are different in different countries. Perhaps authors can consider addressing same in limitations.</p><p>**********</p><p>7. PLOS authors have the option to publish the peer review history of their article (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#8220;no&#8221;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p><p>Reviewer #2:&#160;No</p><p>Reviewer #3:&#160;No</p><p>**********</p></body></sub-article><sub-article article-type="editor-report" id="pone.0294804.r004" specific-use="acceptance-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0294804.r004</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bluthenthal</surname><given-names initials="RN">Ricky N.</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#169; 2023 Ricky N. Bluthenthal</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ricky N. Bluthenthal</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1371/journal.pone.0294804" id="rel-obj004" related-article-type="reviewed-article"/></front-stub><body><p>
<named-content content-type="letter-date">5 Dec 2023</named-content>
</p><p>PONE-D-22-25311R1 </p><p>Harm reduction strategies in acute care for people who use alcohol and/or drugs: A scoping review </p><p>Dear Dr. Curran:</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p><p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p><p>If we can help with anything else, please email us at <email>customercare@plos.org</email>.</p><p>Thank you for submitting your work to PLOS ONE and supporting open access. </p><p>Kind regards, </p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Dr. Ricky N. Bluthenthal </p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article></article></pmc-articleset>